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ABSTRACT 
 
 A set of fluorescent sensors was synthesized to detect two different types of 
lipids. A coumarin aldehyde that reversibly forms imines with primary amines in water 
was developed to selectively detect the lipid head group phosphoserine. A zinc (II) 
dipicolylamine was appended to the coumarin fluorophore by either a methylphenyl or 
propyl linker. Titration data showed significantly better binding for the propyl-linked 
sensor, likely due to conformational restrictions of the phenyl group. The propyl-linked 
sensor was determined to have a binding constant of 310 M
-1
 for phosphoserine at 
physiological pH, with a 30-fold fluorescence enhancement. In addition, sensors were 
synthesized for detection of oxidized phospholipids based on recognition of aldehydes 
produced from oxidative cleavage of unsaturated lipids. Molecular tubes have previously 
been reported with selectivity for saturated fatty acids. Based on this work, two “open” 
molecular tubes were synthesized that shared some of the original molecular tubes’ 
affinity for hydrophobic guests, but that also had either a hydrazone or hydrazide capable 
of forming hydrazones with aldehydes. The hydrazone version gave a binding constant of 
51 M
-1
 towards hexanal, while the hydrazide was not photostable in the presence of 
aldehyde. 
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Chapter 1: Molecular Recognition 
 
 
 
1.1 Overview 
Molecular recognition is the association of two or more molecules through 
reversible non-covalent interactions.
1
  These interactions include ion-ion, dipole-dipole, 
metal-ligand, hydrogen bonding, π- π stacking, van der Waals, or hydrophobic 
interactions.
2
 Molecular recognition is the basis for DNA base pairing, protein-substrate 
interactions, and self-assembly of micelles in water. While molecular recognition has 
historically relied exclusively on non-covalent forces, increasing attention has been paid 
to functional groups that rapidly and reversibly form covalent bonds. Boronic acids, 
which form boronate esters with catechols and saccharides, and coumarin aldehydes, 
which react with amines to form imines, are of particular interest. 
In discussing molecular recognition between two different molecules or ions, the 
species involved are often categorized as either a host or a guest. As an example, in 
biochemistry an enzyme would be considered a host, and the substrate for the enzyme 
active site would be a guest. For synthetic systems, host molecules are designed to 
complement the structure of the intended guest. 
 
1.2 Recognition of Ionic Species 
The simplest and most well-studied molecular recognition systems are metal ion 
receptors. One of the earliest metal ion hosts to be studied was ethylenediaminetetracetic 
2 
 
acid (EDTA) (Scheme 1). Because it is capable of binding to metals through six atoms 
simultaneously, EDTA shows very strong binding affinity for many metal ions. This has 
led to its wide-spread use for removing unwanted metals in a number of industrial 
settings, and more commonly encountered in daily life, as an additive to soap and 
shampoo to counteract the effects of the ions that cause “hard water.” 
 
Scheme 1  EDTA-metal ion binding 
 
 
 
In 1967, Pedersen reported the synthesis of a number of cyclic oligomers of 
ethylene oxide.
3
 The simplest of these crown ethers show selectivity for different metal 
ions based on size, with 12-crown-4 being selective for the tiny lithium cation, 15-crown-
5 for sodium, and 18-crown-6 for the significantly larger potassium ion (Figure 1). When  
 
Figure 1  Crown ethers with alkali metal cations. 
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complexing a metal ion, the oxygen atoms are all oriented towards the center of the ring, 
leaving only the hydrophobic ethylene units exposed to solvent. This allows the crown 
ether to transfer otherwise insoluble ions into organic solvents. A number of derivatives 
have since been made that substitute some of the oxygen atoms in these rings with 
nitrogen or sulfur. These aza- and thio-crown ethers have altered selectivity, allowing for 
the selective recognition of alkaline earth metals, various transition metals, mercury, lead, 
etc. 
 
1.3 Hydrogen-Bonding Receptors 
In general, hydrogen-bonding receptors are quite effective in organic media, 
particularly in less polar sytems where the polar host and guest would preferentially 
interact with one another instead of the non-polar solvent. In polar solvents, especially 
water, the guest and host are both well solvated, and host-guest binding requires 
displacement of enthalpically favorable solvent shells, significantly shifting the 
equilibrium away from the host-guest complex. 
Because of the importance of hydrogen bonding to biological systems, significant 
work has been done on the development of rigid hydrogen-bonding systems that mimic 
the types of arrangements found in DNA base pairs (Figure 2a) and protein β sheets 
(Figure 2b). 
Because of the high degree of symmetry they display, urea, benzamidines and the 
guanidinium ion have received particular attention.
4-7
 A number of receptors for the 
recognition of guanidinium species, including the amino acid arginine, have been 
 
4 
 
Figure 2  (a) Hydrogen bonding between thymine and adenine (top) and guanine and 
cytosine (bottom).  (b) Hydrogen bonding in an anti-parallel protein β sheet. 
 
a)           b)    
 
developed (Figure 3).
8
 To accommodate the planar guanidinium ion, optimal receptors 
are generally also planar. The symmetry of guanidinium makes it relatively simple to 
design receptors with near-optimal hydrogen bond angles and lengths, 180º and 
approximately 3 Å, respectively. 
 
Figure 3  Hydrogen-bonding receptor for arginine. 
 
 
 
5 
 
The crown ethers mentioned above have also seen use as receptors for hydrogen-
bonding guests, including hydronium, ammonium, and lysine cations (Figure 4).
9-12 
 
Figure 4  18-Crown-6 hydrogen-bonding complex with lysine. 
 
 
 
1.4 Hydrophobic Interactions 
Water is unique in that each molecule can form four hydrogen bonds to four other 
solvent molecules simultaneously (Figure 5). This leads to extensive networks of 
hydrogen bonding in water that must be disrupted in order to make room for any solutes, 
at a relatively high energetic cost compared to most other solvents. 
 
Figure 5  Hydrogen bonding interactions of water molecules. 
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When hydrophobic molecules are dissolved in water they create a hole in the 
hydrogen bond network, replacing strong hydrogen bonding interactions with 
significantly weaker dipole-dipole and/or van der Waals interactions. If the hydrophobic 
solute molecules associate together, excluding water from between them, the water-solute 
interactions are minimized and the water-water hydrogen bonding interactions are 
maximized (Scheme 2). This overall energy optimization is what leads to the spontaneous 
formation of miscelles when lipids are suspended in water. 
 
Scheme 2  Hydrophobic effect for hexane. 
 
 
 
Molecular recognition based on hydrophobic interactions is well-known for  a 
wide variety of systems including cavitands, carcerands, molecular clips and 
molecular tweezers. Cyclodextrin (Figure 6), a conical oligomer of glucose, was one of 
the first receptors discovered that uses a hydrophobic cavity for the encapsulation of a 
guest molecule (Scheme 3).
13 
 
 
 
7 
 
Figure 6  Structure of β-Cyclodextrin. 
 
 
 
The rigid structure of the macrocycle is enforced, in part, by intramolecular 
hydrogen bonding on the interior surface of the cone. With these hydrogens and oxygens 
already involved in strong hydrogen bonding, they are less available for interactions with 
other molecules inside the cavity. This makes the inside of the cone much less polar than  
 
Scheme 3  Host-guest complex formation between β-cyclodextrin and cholesterol. 
 
 
 
 
8 
 
the exterior surface, and very greatly less polar than the bulk solvent. This leads to the 
inclusion of hydrophobic molecules inside the cone. A number of different cyclodextrin 
oligomers exist that vary only in the size of the cavity, allowing for some selectivity in 
which hydrophobic guests are incorporated into the receptor based on complimentary fit 
of size and shape. 
 
1.5 Reversible Covalent Binding 
 While the term “molecular recognition” is typically reserved for non-covalent 
interactions, discrimination can be achieved between a receptor and its substrate by 
interactions that are covalent in nature but exist in equilibrium. The most well-studied 
examples to date are the boronic acids, which reversibly form esters with diols in aqueous 
solution (Scheme 4).
14
 This reaction leads to their use as receptors for sugars, especially 
glucose, whose concentration in blood needs to be regularly monitored by the over 25 
million people in the United States who suffer from diabetes.
15
 
 
Scheme 4  Formation of boronate ester between phenylboronic acid and glucose. 
 
 
 
 Shinkai developed one of the first boronic acid receptors selective for glucose 
over other monosacharides.
16
 This diboronic acid was shown to selectively recognize 
glucose over other mono- and disaccharides by circular dichroism (Scheme 5). Glucose 
9 
 
binds to the receptor 190 times more favorably than the next strongest-binding analyte, 
maltose. 
 
Scheme 5  Binding of glucose to a diboronic acid receptor. 
 
 
 The reversible reaction between aldehydes and primary amines to form imines has 
also sparked a great deal of interest. The Glass group has used coumarin aldehydes to 
determine concentrations of a number of biologically active amines under physiological 
conditions as well as in cells.
17 
A recent example of amino acid sensing by imine 
formation is shown in Scheme 6. Kynurenine, a metabolite of the amino acid tryptophan,  
 
Scheme 6  Coumarin aldeyde sensor for kynurenine. 
 
 
 
10 
 
selectively reacts with 7-diethylamino-4-ethylthio-coumarin-3-carbaldehyde over other 
biological amines at low pH.
18
 
 
1.6 Chelation and Preorganization 
The strength of interaction between molecules A and B when they form 
supramolecular complex AB (Equation 1) is characterized by the association constant, Ka 
(Equation 2).  
 
                                             eq. 1     
 
    
    
      
   eq. 2     
 
In molecules that have multiple recognition elements to interact with a single 
guest, Ka will be increased by the chelation effect. The equilibrium constant is related to 
the Gibbs free energy ( ΔG) of the interaction by Equation 3, where R is the ideal gas  
 
               eq. 3     
 
constant, T is the temperature. ΔG has a dependence on entropy (ΔS) (Equation 4). 
  
           eq. 4     
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For the formation of a 4:1 complex between ammonia and copper (II) ion 
(Scheme 7), there is a decrease in the total number of particles from five to one, causing a 
large decrease in the translational entropy of the system. A decrease in entropy makes ΔG 
more positive, and thus the reaction less favorable. 
 
Scheme 7  Coordination of ammonia to copper (II) ion. 
 
 
 
For complexation of ethylenediamine to Cu
2+
 (Scheme 8), the change in enthalpy 
is approximately the same because the same number of N-Cu dative bonds are made, but 
the decrease in translational entropy is much smaller since the number of particles only 
decreases from three to one. The smaller negative value of ΔS makes ΔG more negative  
 
Scheme 8  Coordination of ethylenediamine to copper (II) ion. 
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for [Cu(en)2]
2+
 than for [Cu(NH3)4]
2+
 and thus the formation of [Cu(en)2]
2+
 is more 
favorable than that of [Cu(NH3)4]
2+
. This is the chelation effect. 
Just as the chelation effect makes host-guest interactions with multiple binding 
sites more favorable thermodynamically by reducing the translational entropic cost of 
binding, when the host molecule also has its binding sites in a closed ring there is an 
additional “macrocyclic effect” that increases the value of Ka by decreasing the amount 
of rotational entropy that is lost upon binding. In the open-chain oligo-ether shown in 
Figure 7, binding to the potassium ion with all six oxygens requires a specific 
conformation of the host chain, severely restricting its ability to rotate freely about it's C-
C and C-O bonds. In the macrocyclic crown ether, the rotational freedom was lost in the 
synthesis of the receptor, long before the binding event occurred. In this case, there is 
very little loss of rotational entropy on binding the potassium ion, and so ΔG is 
significantly more negative for the macrocycle than it is for its open-chain counterpart. 
 
Figure 7  Macrocyclic effect for 18-crown-6. 
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1.7 Conclusion 
 Molecular recognition covers a wide variety of reversible interactions for the 
association of two or more molecular species in solution. The strength of the interaction 
is dependent on complementarity of size, shape and charge between the receptor and its 
guest. These parameters allow for optimization of binding strength for a wide variety of 
chemical species. The extent of host-guest complex formation is quantified by the 
association constant, Ka, which is also related to the strength of the binding interaction. 
Molecular recognition has applications for cleaning, catalysis, and chemical sensing, 
among many others.  
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Chapter 2: Chemical Sensing 
 
 
 
2.1 Overview 
Chemical sensing
19,20
 occurs when a molecular recognition event corresponds 
with a measurable change in some property of the system being studied. Useful properties 
for sensing include electrical potential (potentiometry), current (amperometry), 
absorbance of light (colorimetry), and emission of fluorescence (fluorimetry). 
Colorimetry and fluorimetry use similar instrumentation that is easy to operate 
and can be portable. They both give results that can often be detected by the human eye 
for qualitative detection, can often be used on liquid samples without further sample 
preparation and have fast response times that can allow for real-time monitoring. Both 
methods are also biocompatable and non-destructive. Fluorimetry has the added bonus of 
usually having much lower background signal over colorimetry due to the fact that many 
molecules absorb light but very few fluoresce, leading to a lower limit of detection. These 
properties lead to fluorescence being an ideal method of detection in complex biological 
samples and cellular environments. 
 
2.2 Fluorescence 
Fluorescent molecules (fluorophores) are organic compounds with extensive 
conjugated π-systems. Fluorescence occurs due to electron transitions between the 
highest occupied molecular orbital (HOMO) and the lowest unoccupied molecular orbital 
15 
 
(LUMO). The larger the conjugated π-system, the smaller the HOMO-LUMO energy gap 
becomes, resulting in photon absorption and emission at longer wavelengths. 
Fluorescence begins when the fluorophore absorbs a photon.
21
 The energy 
absorbed promotes an electron from the electronic ground state, S0, to an electronically 
excited state, often the lowest-lying excited state, S1, without changing the spin of the 
electron. The excitation energy promotes the electron to a vibrationally excited level of 
S1, and the molecule subsequently relaxes, lowering the electron to the vibrational ground 
state of S1 by transferring energy collisionally to the solvent. From here the electron 
drops to a vibrationally excited state of S0 and emits a photon with an energy equal to the 
difference between these two energy levels. These photophysical processes are 
represented as a Jablonski diagram (Figure 8). Not every photon that is absorbed leads to  
 
Figure 8  Jablonski diagram. 
 
 
16 
 
the emission of another photon (vide infra).The ratio of photons emitted per photon 
absorbed is referred to as the quantum yield, Φ.  
Arrow A is the excitation event. The electron is most likely to occupy the lowest 
vibrational energy level of the fluorophore, and so most excitation events occur from the 
vibrational ground state. In this example, the molecule is excited, promoting an electron 
to a vibrationally excited state of the second electronic excited state, a process which 
takes approximately 10
-15
 seconds and can be practically approximated as instantaneous. 
The molecule relaxes vibrationally until the electron reaches the vibrational ground state 
of S1 (arrow B). This vibrational relaxation occurs in approximately 10
-12
 seconds. In the 
next 10
-8
 seconds, the electron drops from S1 to a vibrationally excited level of S0, 
emitting a photon in the process (arrow C), before finally relaxing to the vibrational 
ground state of S0 (arrow D).  
The majority of molecules that absorb light do not fluoresce. There are a number 
of reasons for this, with the most important ones being internal conversion (vide supra) 
from S1 to S0, energy transfer to solvent, and intersystem crossing. Collisions with 
solvent molecules lead to a transfer of energy from the fluorophore to the solvent, 
dropping the excited electron to the electronic ground state. Intersystem crossing, 
represented in Figure 1 as arrow E, occurs when the excited electron changes its 
multiplicity, going from the singlet S1 state to the triplet T1. This is a forbidden transition 
by quantum mechanical selection rules, and so the probability of occurrence is typically 
small. In molecules that do exhibit intersystem crossing, the relaxation from T1 to S0 is 
also a forbidden transition, as is reversing from T1 back to S1. As a result, the lifetime of 
the excited state is extended significantly. This results in a decrease in fluorescence 
17 
 
through allowing more time for non-radiative decay pathways such as collisional 
quenching by other molecules, as well as reducing the number of radiative decay 
pathways that can occur at once so that some luminescence does occur, but the intensity 
is too low to be detected easily. Radiative decay from the triplet state is called 
phosphorescence (arrow F), and can occur over a range of time from microseconds to 
hours. 
From this qualitative diagram, it can be seen that arrow A must be longer than 
arrow E, and so the emitted photon has less energy than the absorbed photon. The 
excitation occurs at a shorter wavelength (more blue) and the emission at a longer 
wavelength (more red). This phenomenon is the Stokes shift
21
 of the fluorophore, which 
is measured as the difference between the wavelength of maximum excitation and 
wavelength of maximum emission (Figure 9). The magnitude of the Stokes shift depends 
on the fluorophore, and often on the solvent. 
 
Figure 9  Stokes shift between absorbance maximum and fluorescence maximum. 
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2.3 Intramolecular Charge Transfer and Solvatochromism 
Solvent effects on the Stokes shift are referred to as solvatochromism, and it is 
especially pronounced in molecules that display intramolecular charge transfer (ICT). In 
these molecules an electron donor is in conjugation with an electron acceptor, giving rise 
to resonance structures such as those shown for dansyl amide (Figure 10).
22 
 
Figure 10 Major resonance contributors of dansyl amide. 
 
 
 
Compound 1 is uncharged, while resonance structure 2 has separated charges. The 
ground state of the fluorophore most closely resembles 1, while the first excited state 
electron distribution is very similar to 2. This leads to preferential stabilization of the 
excited state with respect to the ground state in polar solvents, resulting in a decrease in 
the energy of emitted light without significantly affecting the wavelength of excitation. 
As Figure 11 demonstrates, placing dansyl amide in a more polar solvent red-shifts the 
fluorescence, while putting it in a less polar solvent blue-shifts the emission spectrum.  
 
19 
 
Figure 11  Normalized fluorescence spectra of dansyl amide in cyclohexane (CH), 
dichloromethane (DCM), ethanol (EtOH), bmimPF6 (IL), 90 wt% glycerol in water 
(GW), and water.
22
 
 
 
 
In Figure 11, the relative intensities of dansyl amide have been normalized for 
each spectrum. Like the wavelength of maximum emission (λmax), the intensity of  
fluorescence emission (I) for 1 also varies with solvent polarity. Normalization removes 
the confounding variable of intensity in order to make it easier to determine differences in 
emission wavelength between the spectra. Normalization sets the amplitude of the 
maximum emission wavelength for each spectrum to the same arbitrary number, typically 
one, making it easier to compare not only λmax values but also features such as the shape 
and breadth of the emission peak(s), which can provide information about molecular 
structure, ionization state, and intermolecular complex formation, between different 
spectra of varying intensities. 
20 
 
Solvatochromism allows the measurement of solvent polarity in the environment 
around a fluorophore.  2,5-(4′-nitrophenylethenyl)-styrylfuran (3, Figure 12) shows a 
dramatic red-shift in fluorescence of almost 250 nm as the molecule is dissolved in more 
 
 
Figure 12  Structure of 2,5-(4′-nitrophenylethenyl)-styrylfuran. 
 
 
 
polar solvents (Figure 13).
23
 This property has been put to use extensively in the probing 
of cellular environments for determining the relative fluidity of membranes.
24-27
 
 
Figure 13 Emission spectra of 2,5-(4’-nitrophenylethenyl)-styrylfuran in (left to right) 
isopentane, hexane, cyclohexane, carbon tetrachloride, toluene, ethyl acetate, 
bromonaphthalene, acetone, and acetonitrile.
23 
 
 
21 
 
Solvatochromism is only one way of changing fluorescence output. Modification 
of the π-system, quenching, photoinduced electron transfer, Förster resonance energy 
transfer (FRET), and excimer formation have all been used to indicate changes in 
environment and the presence of chemical species.
28-30 
 
2.4 π-System Modification 
Binding events that extend or reduce the degree of π-system conjugation lead to 
shifts in the wavelength of light absorbed or emitted. Michael acceptors are a particularly 
common sensing motif for reversible soft nucleophiles, as conjugate addition results in  
the loss of a π-bond. Sensor 4 was developed for detection of sulfite anion (Scheme 9).31 
Malonitrile is conjugated to the coumarin fluorophore, leading to long wavelengths of 
absorption (492 nm) and emission (578 nm) due to the extended conjugation. On addition 
of sodium sulfite, a rapid change in color is observed due to the 1,4-addition of sulfite, 
resulting in new, lower wavelengths of absorption and emission (413 and 480 nm, 
respectively). 
 
Scheme 9  Coumarin sensor for sulfite anion. 
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A different mode of π-system modification can be seen in Scheme 10.32 
Compound 5 is a pyridine-containing analog to the green fluorescent protein (GFP) 
fluorophore. In solution the double bond connecting the two ring systems undergoes E,Z 
isomerization upon excitation instead of fluorescing, effectively quenching  emission. 
Upon chelating a zinc ion, the two rings are brought into a rigid, near-planar structure, 
enforcing the conjugation between the two ring systems and turning on the fluorescence. 
 
Scheme 10  Fluorescent zinc sensor. 
 
 
 
2.5 Fluorescence Quenching 
Quenching is a decrease in fluorescence intensity. Collisional quenching occurs 
when two molecules come in contact transiently in solution. Oxygen and halide ions are 
well-studied collisional quenchers that act through a process called spin-orbit coupling, 
which increases the rate of intersystem crossing, preventing radiative decay from S1 to S0. 
In oxygen, this occurs due to the triplet nature of the molecule’s ground state, while in 
chloride, bromide, iodide, and several metal species the phenomenon is referred to as the 
heavy atom effect.
21
 Sensors for halides have been developed based on this fact,  
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Figure 14  Acridinium fluorescent sensor for iodide. 
 
 
 
including 6 (Figure 14).
33
 The positive charge on the fluorophore attracts the negative 
iodide, and iodide’s proximity leads to quenching of the fluorophore by spin-orbit 
coupling. 
The decrease in fluorescence intensity makes 6 a turn-off sensor. Turn-off is a 
valid sensing option, but its reliability is limited by the fact that there are many different 
ways that fluorescence can be reduced, including quenching by species other than the 
desired analyte, particularly molecular oxygen, decomposition of the fluorophore, and 
photobleaching. 
 
2.6 Photoinduced Electron Transfer (PET) 
During excitation, the fluorophore has two half-filled orbitals with a significant 
energy gap between them. If another molecule, or a part of the same molecule that is not 
conjugated with the fluorophore, has a HOMO or LUMO within this energy gap, 
photoinduced electron transfer (PET) can occur in one of two ways (Figures 15 and 16).  
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If the HOMO of the other molecule is higher than the HOMO of the fluorophore 
it can transfer an electron into the lower energy, half-empty fluorophore orbital. This 
process is referred to as acceptor-PET (a-PET) since the fluorophore is acting as an 
electron acceptor (Figure 15). 
 
Figure 15  HOMO-LUMO energy diagrams for electron transfer between excited 
fluorophore and nearby electron donor. 
 
 
 
If the LUMO of the other molecule is higher than the HOMO of the fluorophore 
the excited electron can transfer from the fluorophore LUMO to the LUMO of the second 
molecule, instead of dropping to the fluorophore HOMO and directly fluorescing (Figure 
16). This mechanism is refered to as donor-PET (d-PET), with the fluorophore acting as 
an electron donor. 
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Figure 16  HOMO-LUMO energy diagrams for electron transfer between excited 
fluorophore and nearby electron acceptor. 
 
 
 
In Scheme 11, 7 is composed of a BODIPY fluorophore with a diaminobenzene 
moiety attached at the meso position.
34 
The diaminobenzene unit is not conjugated with 
the fluorophore due to steric interactions between the ortho hydrogens and the two 
methyl groups forcing the ring to twist out of the plane of the BODIPY. In 7, the 
fluorophore is PET quenched by the HOMO electrons of the electron-rich 
diaminobenzene, making this an example of a-PET. In the presence of methylglyoxal, the 
aniline nitrogens are converted to imines. This transformation changes the arene pi-
system from being quite electron-rich to relatively electron-poor, lowering its HOMO 
energy level below that of the fluorophore, and thus preventing PET quenching and 
increasing fluorescence intensity. This is an example of a turn-on sensor. 
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Scheme 11  BODIPY a-PET sensor for methylglyoxal. 
 
 
 
2.7 Conclusion 
 Chemical sensing uses molecular recognition to quantify the concentration of a 
particular analyte in a system. Fluorescence is a particularly useful output for sensors 
since it is non-destructive, non-invasive, and fast. There are a variety of ways to modulate 
fluorescence output, either by turning the emission on or off or changing the wavelength 
of the emission on interacting with the analyte.  
 
 
 
 
 
 
 
 
27 
 
Chapter 3: Lipids 
 
 
 
3.1 Overview 
 Lipids (Figure 17) are a large class of biomolecules that are either hydrophobic or 
amphipathic, and so have limited solubility in water. Their most important role is as the 
primary components of cellular membranes, which protect the cell and allow 
compartmentalization of cellular processes. In eukaryotes the most common lipid classes 
are fatty acids (8), triglycerides (9), phospholipids (10), sphingolipids (11), and terpene 
derivatives (12).
35 
 
Figure 17  Common categories of lipids. 
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A fatty acid (8) is a long-chain carboxylic acid, most often containing between 12 
and 20 carbon atoms.
36
 Fatty acids chains can be saturated, unsaturated or 
polyunsaturated. In addition to comprising an important and structurally diverse category 
of lipids in their own right, fatty acids are also a major component in other lipids classes, 
since triglycerides, phospholipids and sphingolipids all have one or more fatty acid esters 
in their structures. They are most commonly found as components of more complex 
lipids. Triglycerides, or triacylglycerols, are triesters of fatty acids and glycerol (9). They 
are primarily involved in energy storage in animals and are stored in adipose tissue.
37
  
Phospholipids (10) are the main component of cellular membranes, and are 
responsible for a number of cell to cell signaling pathways including clotting and 
apoptosis. Most phospholipids are diacylphosphoglycerides, with the phosphate on the   
3-position of the glycerol (Figure 18). The most common groups attached to the 
phosphate are choline (13), which accounts for 35-45% of all phospholipids in cell 
membranes, ethanolamine (14, 22-29%) and serine (15, 12-19%).
38
 For all phospholipids, 
 
 
Figure 18  Common phospholipid head groups. 
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the two fatty acid chains are anchored in the membrane, while the phosphate group is 
exposed to the water outside the membrane. 
Sphingolipids (11, Figure 19) are also a major component of cellular membranes, 
but they differ from phospholipids in that they contain a sphingosine (16) backbone with 
one fatty acid residue attached at the 2-amino position of sphingosine. The terminal 
hydroxy group can be substituted with a phosphate ester, as with phospholipids, which 
results in a sphingomyelin molecule (17), or to a sugar acetal, producing a cerebroside 
(18).
39 
 
Figure 19  Sphingosine (16) and common sphingolipids. 
 
 
 
 Terpene derivatives (12) are formally oligimers of isoprene, 2-methyl-1,3-
butadiene. In cell membranes, cholesterol (19) is the predominant terpene derivative 
present. Cholesterol is a member of the steroid class of terpenoids, which also includes 
30 
 
testosterone, estradiol, and bile acids.
40
 Other important terpenoids include retinal (20), 
which is the active form of vitamin A necessary for retina function, carotenoids such as 
β-carotene and lycopene, xanthophylls which give rise to autumn leaves’ colors, and 
natural rubber, a polymer of isoprene.
35 
 
Figure 20  Structures of cholesterol (19) and retinal (20). 
 
 
 
3.2 Low-Density Lipoprotein 
 A significant amount of lipid synthesis occurs in the liver. These lipids need to be 
transported from the liver to other sites in the body where they are needed for energy 
production, as components of new cell membranes during cell growth or division, or to 
be stored in adipose tissue for future energy needs. Individual lipid molecules are 
insoluble in water, and so for transport they are packaged into lipoprotein particles. The 
lipoprotein is a micelle with an outer surface of phospholipids and cholesterol and a 
single protein, called an apoprotein. The interior of the particle is an aggregate of 
triglycerides and esterified cholesterol, which are completely insoluble in water.  
31 
 
 The two primary categories of lipoprotein are low-density lipoprotein (LDL) and 
high-density lipoprotein (HDL).
40,41
 LDL packages lipids in the liver for transport out to 
the rest of the body. The apoprotein binds to cellular receptors, which triggers 
endocytosis. Excess lipids are transported back to the liver for degradation by HDL. High 
levels of LDL and low levels of HDL correlate with increased risk of heart disease, 
particularly atherosclerosis.
42,43
 
 
3.3 Oxidized Phospholipids and Atherosclerosis 
 Atherosclerosis is the thickening and hardening of arterial walls due to the 
formation of plaques. Rupturing of these plaques leads to blood clots in arteries, blocking 
blood flow and eventually leading to heart attacks and strokes.  Oxidation of unsaturated 
phospholipids on the surface of LDL particles is a triggering event in the formation of 
arterial plaques.
44-46
 
 LDL particles can penetrate the outer tissue layer of the arterial wall, where they 
become oxidized. Unsaturated phospholipids undergo oxidation at the carbon-carbon 
double bond due to the action of radicals, including nitric oxide and other reactive 
oxygen species, as well as by certain enzymes such as lipoxygenase.
47
 Oxidation leads to 
a number of epoxide, hydroxide and oxo products. Oxidative cleavage of the double bond 
in phospholipids containing an unsaturated fatty acid results in formation of an aldehyde 
at the cleavage site (Scheme 12).
48 
Aldehydes on LDL particles are recognized by receptors on macrophages which 
then engulf the particle.
49
 The macrophages are incapable of completely digesting the 
LDL particles and continue engulfing particles until they burst. This releases the oxidized 
32 
 
Scheme 12  Oxidative cleavage of unsaturated phospholipid to an aldehyde. 
 
 
 
phospholipids where they can then trigger consumption by more macrophages. The burst 
cells also release inflammatory molecules that trigger further immune responses leading 
to swelling and further action by macrophage cells, growing the developing plaque into 
the artery, which restricts blood flow and raises blood pressure. Further growth damages 
the surrounding tissue until the plaque ruptures, releasing fat deposits, fibrous material 
and clotting factors that restrict blood flow, resulting in heart attacks and strokes.
 
 
3.4 Current Detection Methods 
 Early detection of oxidized phospholipids is desirable for the prevention of heart 
attacks and strokes, as well as the early treatment of other symptoms of cardiovascular 
disease. Currently, atherosclerosis is detected most readily by invasive angiography of 
arteries, and is only detectable once the plaque is well-developed.  
33 
 
 Detection of higher levels of oxidized LDL particles in blood correlates with 
atherosclerotic plaque growth, and is a minimally invasive technique.
50
 At present, the 
majority of work on the detection of oxidized phospholipids in blood and serum requires 
mass spectroscopy, which has limitations for clinical applications.
51-57
 The samples are 
complex, requiring separation by electrophoresis or liquid chromatography, and a large 
number of similar lipids are present that may be modified in many different ways, which 
makes analysis of the mass spectrum complicated. In addition, the instrumentation is 
relatively expensive and requires significant training to use, which may be cost-
prohibitive for many clinical settings. 
 Attempts have been made to detect oxidized phospholipids by other means, 
including x-ray diffraction of cellular membranes,
58,59
 absorbance spectroscopy of 
antibodies that target oxidized lipids,
60
 and fluorescence spectroscopy of environment-
sensitive membrane probes. Howlett’s group59 has been able to show that the ratio of 
oxidized phospholipid in LDL particles is proportional to the intensity of fluorescence 
from thioflavin T (Figure 21, 21), a common fluorescent stain for protein aggregates, and  
that oxidation of LDL particles also causes birefringence with the Congo Red dye (22) 
when viewed under polarized light that is similarly proportional to the ratio of oxidized 
phospholipids in the micellular membrane. 
 Jungwirth et al.
61
 demonstrated that cellular membranes become more permeable 
to water as the oxidized phospholipid content increases, a result of less tight packing in 
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Figure 21  Structures of fluorescent membrane probes for oxidized phospholipids.  
 
 
 
the lipid bilayer, by using the polarity-sensitive fluorophore Laurdan (Figure 22, 23). 
They further explored the effect of increased levels of oxidation by monitoring membrane 
fluidity and mobility with a BODIPY lipid derivative, BODIPY C12-HPC (24). 
 
Figure 22  Structures of fluorescent membrane fluidity probes. 
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 In the above cases, while the data correlate with changes in oxidized phospholipid 
content, there was no attempt to quantify the amount of oxidized lipid in a sample based 
on fluorescence measurements. Fluorescence measurements using selective 
chemosensors would be preferable to the mass spectrometry techniques currently 
employed for quantitative analysis in that it could be done on complex samples with little 
to no sample preparation or purification, with simple instrumentation requiring a 
minimum of training to operate and low maintenance expense.  
 
3.5 Conclusion 
 Lipids are important for maintaining cellular structure, storing energy for future 
metabolic needs, and are involved in a wide variety of intercellular signaling processes. 
Intercellular signaling by oxidized phospholipids on the surface of LDL particles is 
implicated in the development of atherosclerosis, one of the leading causes of death in the 
United States. Early diagnosis of atherosclerosis by the detection of oxidized 
phospholipids could lead to better preventative treatment and reduce deaths from heart 
attacks and strokes. 
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Chapter 4: Calixarenes 
 
 
 
4.1  Overview 
Calixarenes are macrocycles formed by the condensation of equal amounts of an 
aldehyde and an electron-rich aromatic ring, typically a phenol. Phenolic calixarenes 
allow for intramolecular hydrogen bonding, which gives them the cup shape for which 
they are named (Figure 23). The easiest calixarenes to prepare are the 4-subunit 
oligomers, calix[4]arenes, although up to calix[8]arenes can be prepared with reasonable 
efficiency.  
 
Figure 23  General structure of calix[4]arene. 
 
 
 
 The basic calixarene motif is very versatile. In addition to substituted benzene, 
calixarenes have been made with pyroles,
62-64
 furans,
65
 (Figure 24, 25) and naphthalenes 
37 
 
(26).
66,67
 They have been used as surfactants
68,69
 and phase-transfer catalysts,
70-72
 
molecular probes,
73
 and catalysts.
74
  
 
Figure 24  Heteroaromatic (25) and naphthyl (26) calix[4]arenes. 
 
 
 
Calixarenes have been studied for a wide range of applications, but their pre-
organized cavity has led to extensive use as molecular receptors. The cavity can either 
interact hydrophobically for binding non-polar molecules, including fullerenes
75,76
 and 
hydrocarbons
77
 or as an electron-donor for binding cations
78,79
 and metal nanoparticles.
80
 
 
4.2  Design of Novel Calixarene 
 Based on the large-cavity naphthalene-based calixarenes already reported,
66,67
 the 
Glass group decided to extend the library of calixarenes to include the 1,8-naphthyridine 
compound 27 (Figure 25). Naphthyridines are too electron-poor to perform the typical 
aldehyde condensation used to form many other calixarenes, and so Buchwald-Hartwig  
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Figure 25  Structure of naphthyridine-based calix[4]arene. 
 
 
 
palladium cross-coupling was used to place a nitrogen bridge between the naphthyridine 
units instead of methylene. 
While phenolic calixarenes have hydrogen bonds that affect the shape of the 
cavity, the nitrogen lone pairs of this naphthyridine-based calixarene are expected to 
allow cation coordination to affect the cavity geometry. Two possible binding modes 
include metal chelation between two adjacent naphthyridine units (Figure 26, 28) and 
hydrogen-bonding by guanidinium or amidinium to both nitrogens of a single 
naphthyridine unit (29). Figures 27 and 28 show computer models of 28 and 29, 
respectively, indicating the unique three-dimensional structure each complex is expected 
to take upon binding. In each of these figures the methoxybenzene units have been 
removed for clarity. 
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Figure 26  Metal (28) and amidinium (29) coordination to calix[4]naphthyridine. 
 
 
 
 
 
Figure 27  Spartan model of metal-bound calix[4]naphthyridine (28).
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Figure 28  Spartan model of amidinium-bound calix[4]naphthyridine (29). 
 
 
 
 
 
 
 
 
 
4.3  Synthesis of Naphthyridine-Based Calixarene 
2,6-Diaminopyridine was combined with d,l-malic acid in concentrated sulfuric 
acid and heated to 120 ⁰C to produce 1,8-naphthyridine 30 with greater than 90% yield. 
The amine was converted to a diazonium by reaction with sodium nitrite in concentrated 
sulfuric acid, and a water work-up afforded the 2,7-diol 31 in 85% yield (Scheme 13).  
 
Scheme 13  Synthesis of 2,7-dihydroxy-1,8-naphthyridine 
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Diol 31 was reacted with phosphorus oxychloride and phosphorus pentachloride 
at 120 ⁰C to afford the 2,7-dichloro compound 32 with 44% yield. Buchwald-Hartwig 
amination of dichloride 32 with 4-methoxyaniline, catalyzed by 
tris(dibenzylideneacetone)dipalladium and bis(diphenylphosphino)propane gave 
calixarene 27 with a yield of 10% (Scheme 14). 
 
Scheme 14  Synthesis of calix[4]naphthyridine 
 
 
 
 Compound 27 was recrystalized from a toluene/methanol mixture the resulting 
crystals were used for x-ray crystallography. The resulting structure, shown in Figure 29 
with the methoxybenzene groups removed for clarity, confirms the identity of 27. In the 
crystal, two of the naphthyridine units directly opposite one another are nearly parallel, 
while the others are splayed outward, making an approximately 100° angle with the first 
two naphthyridines.  
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Figure 29  X-ray crystal structure of calix[4]naphthyridine. 
 
   
 
4.4 Conclusions and Future Directions 
 Future work on this project includes attempts to form crystals of calixarene 27 
with metal salts, including copper (II) and silver (I), and hydrogen bond donors, including 
benzamidine, in order to examine the effects binding has on the calixarene geometry. 
Attempts will also be made to extend the calixarene motif to other naphthyridine 
derivatives. 
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Chapter 5: Coumarin Aldehyde Sensor for Phosphoserine 
 
 
 
5.1  Overview 
Phospholipids constitute the dominant class of lipids composing the lipid bilayer 
of cellular membranes and confer structural support, organization of membrane proteins, 
and intercellular signaling mechanisms.
81-86
 Phosphatidylcholine (PC), sphingomyelin 
(SM), phosphatidylethanolamine (PE), and phosphatidylserine (PS) represent over 97% 
of the total phospholipid composition and are asymmetrically distributed between the 
inner and outer leaflets of a cellular membrane.
87
 In quiescent cells, PC and SM 
constitute approximately 87% of the total phospholipid content of the outer leaflet, with 
PS being exclusively restricted to and comprising approximately 30% of the total 
phospholipid content of the inner leaflet (Figure 30). Cell death randomizes the 
asymmetric distribution of phospholipids between the inner and outer leaflets, thereby 
externalizing PS to the outer cell surface.
88–90
 In fact, exposure of PS to the outer leaflet 
of the cellular membrane is the hallmark molecular biomarker for all types of cell death 
and serves as a signal for phagocytosis by providing approximately 10
6–109 binding sites 
per cell.
91 
 
Several methods to tag apoptotic cells and phospho-amino acid residues have 
appeared in the literature.
92–97
 In addition to biological probes (e.g., annexin assays), the 
vast majority of synthetic approaches have focused on detecting anionic phospholipid 
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Figure 30  (a) Common cellular membrane phospholipid head groups. PC = 
phosphatidylcholine, SM = sphingomyelin, PS = phosphatidylserine, PE = 
phosphatidylethanolamine, PG = phosphatidylglycerol, PGP = 
Phosphatidylglucopyranose. (b) Asymmetric phospholipid composition (mol%) of the 
outer and inner leaflets of healthy human cellular membranes.
87 
 
 
 
head groups, which includes phosphoserine. In particular, zinc(II)–dipicolylamine (Zn2+–
DPA) complexes have proven to be admirable receptors for negatively-charged lipid head 
groups and have been used to tag apoptotic cells as well as bacterial cells.
91,92,94,95,98,99
 
These primarily consist of two pre-coordinated Zn
2+–DPA units tethered to a synthetic 
fluorophore that associates with the membrane surface of apoptotic cells through strong 
multipoint interactions with the anionic phospholipid head groups. These molecular 
probes are phospholipid tags and do not operate in a turn-on fashion. By contrast, a turn-
45 
 
on sensor for PS could give quantitative information about the amount of lipid present 
with low background as well as enable new types of experiments such as the ability to 
monitor the progression of cell death in a cell population. 
Recently, we have been exploring the use of water-soluble shape-selective 
molecular tubes for hydrophobic sensing of lipids.
100
 In order to build selective sensors 
for PS, we require a head-group binding unit. We chose to use the highly-water soluble 
head groups as a model system for the analyses to demonstrate sensor efficacy because 
the head groups are the exposed units at the cell surface and the phospholipids lack water 
solubility. The head groups lack the hydrophobic lipid, yet remain functionally equivalent 
to the phospholipids and are reasonable analogues for evaluating head group binding 
units. In the case of phosphoserine, both the head group and PS possess a primary amine 
and an anionic phosphoester. Herein, we present a fluorescent turn-on molecular sensor 
based on the coumarin aldehyde scaffold for the selective recognition and sensing of 
phosphoserine (Figure 31).
101 
 
Figure 31  (a) Structure of NeuroSensor 521. (b) Ditopic sensors for phosphoserine. 
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The ditopic sensors 33 and 34 consist of an aldehyde recognition element that is 
integrated into the coumarin fluorophore and a single Zn
2+
 –DPA recognition element 
appended to the coumarin scaffold to afford reversible binding to the primary amine and 
anionic phosphate moieties of phosphoserine, respectively (Scheme 15). The coumarin  
 
Scheme 15  Ditopic binding of 2–Zn2+ to phosphoserine. 
 
 
 
aldehyde has been shown to effectively produce a turn-on response to amine binding. 
Indeed, NeuroSensor 521 (NS521, Figure 31a) was developed as a monotopic receptor 
for catecholamines and provides a turn-on response in live cells.
102
 In this study, we 
modified the NS521 scaffold by appending a Zn
2+–DPA unit to the C4 position of the 
coumarin with both a rigid and flexible spacer to afford sensors 33 and 34, respectively. 
We hypothesized that a more rigid linker would provide stronger binding to the analyte 
but developed a flexible linker for comparison. Molecular models indicated that the 
methyl phenyl and propyl linkers would provide the optimal spacing for phosphoserine 
(Figure 32). 
47 
 
Figure 32   Spartan models of phosphoserine-bound 33 and 34. 
 
  
 
We reasoned that only phospholipid head groups with primary amines should 
bind to the coumarin aldehyde and form an iminium ion, which causes an approximately 
40 nm bathochromic shift in absorption.
102–104
 By exciting the fluorophore at this new, 
more red wavelength, we can visualize a fluorescence increase due only to the bound 
sensor. The Zn
2+–DPA group is likely the best receptor for phosphates in water and was 
incorporated to achieve selectivity.  
 
5.2 Synthesis of Ditopic Sensors  
The syntheses of sensors 33 and 34 are shown in Scheme 16 and 17, respectively. 
To make sensor 33, compound 35 was coupled via its tosylate to an aryl boronic acid to 
produce compound 36. Chlorination followed by formylation using the Vilsmeier reagent 
gave compound 38, which was alkylated with a dipicolylamine unit to yield sensor 33. 
48 
 
Sensor 34 was prepared from alcohol 39
104
 by conversion to iodide 40 followed by 
alkylation with dipicolylamine. 
 
Scheme 16  Synthesis of sensor 33. 
 
 
 
Scheme 17  Synthesis of sensor 34. 
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5.3 Spectroscopic Properties.  
When unbound, sensor 33 absorbs at 453 nm and emits at 517 nm. The quantum 
yield (Φ) was measured to be 0.0125 using fluorescein as a standard.105 Sensor 34 absorbs 
at 454 nm and emits at 513 nm with a quantum yield of 0.0213. 
 
5.4 Binding Titrations.  
 In order to calculate association constants for sensors 33 and 34, the concentration 
of analyte was plotted against I ∕ Io −1, where I is the fluorescence intensity, Io is the 
initial fluorescence intensity of sensor alone. The plotted data was fit to a one-site 
binding isotherm using Equation 5, where Bmax is the theoretical maximum fluorescence  
 
 
  
   
             
            
  eq. 5     
 
intensity when the sensor is saturated with analyte and Kd is the dissociation constant for 
the sensor-analyte complex. Kd is the inverse of Ka, defined in Equation 2. 
Sensors 33 and 34 were titrated with several phospholipid head groups: 
phosphoserine, phosphoethanolamine, phosphocholine, α-glycerolphosphate, and D-
gluco-pyranose-1-phosphate, as well as the primary amines glutamate and glycine under 
buffered aqueous conditions (50 mM HEPES, 100 mM NaCl, pH 7.4). Glutamate and 
glycine served as controls for amine binding as they lack phosphate groups. The binding 
and spectroscopic data are summarized in Table 1. The absorbance of 33–Zn2+ shifted to 
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Table 1  Binding constants (Ka) and spectroscopic properties of sensors 33 and 34 with 
various analytes.
a 
 
 
 
a
 Analytes of various concentrations were added to sensor (10 μM) in buffer (50 mM 
HEPES, 100 mM NaCl, pH 7.4). Sensor 1 was titrated in 97 : 3 buffer–DMSO and sensor 
2 was titrated in 100% buffer. 
b
 Zinc acetate (10 μM) was pre-coordinated with sensor 
prior to addition of analyte. 
c
 Isat was taken from the theoretical maximum of the binding 
isotherm; λex = 488 nm; λem, 1 = 521 nm, λem, 2 = 513 nm.  
 
488 nm upon the addition of phosphoserine, phosphoethanolamine, glutamate, and 
glycine. Phosphocholine, α-glycerolphosphate, and D-gluco-pyranose-1-phosphate did 
not bind to the coumarin aldehyde of 33–Zn2+ and therefore did not alter the 
spectroscopic properties. All primary amine analytes bound to the coumarin aldehyde 
with low affinity and relatively low fluorescence enhancements (<7-fold) with emission 
maxima at 521 nm when excited at 488 nm. The binding results were similar to the 
control experiments conducted without Zn
2+
 indicating that the Zn
2+–DPA had little 
effect on enhancing analyte binding to the coumarin aldehyde. Indeed, these binding 
constants are similar to those achieved with simple, unsubstituted coumarin 
aldehydes.
102–104
 
Analyte Ka (M
-1
) Isat/Io 
c
Ka (M
-1
) Isat/Io 
c
Ka (M
-1
) Isat/Io 
c
Ka (M
-1
) Isat/Io 
c
Phosphoserine 3.1 7.2 5.4 6.2 120 5.8 310 30
Phosphoethanolamine 5.7 4.8 5.7 4.9 93 9.1 180 39
Glutamate 4.7 7.0 7.0 4.3 22 13 190 17
Glycine 6.1 6.1 6.2 4.0 5.3 16 6.6 29
33-Zn
2+  b33 34 34-Zn
2+  b
51 
 
Sensor 34 displayed similar absorption properties compared to sensor 33. The 
absorbance of 34–Zn2+ also shifted to the red only upon addition of phosphoserine, 
phosphoethanolamine, glutamate, and glycine. As seen with sensor 33, the phospholipid 
head groups that did not contain primary amines did not bind. The binding for 
phosphoserine was remarkably higher than for the other analytes tested with Ka = 310 
M
−1
 (Figure 33).  
For sensor 34, the spectroscopic properties with Zn
2+
 were much more favorable 
than the control experiments without Zn
2+
, though the binding constants of 34 with 
phosphoserine, phosphoethanolamine, and glutamate were elevated compared to the  
 
Figure 33 (a) UV/Vis and (b) fluorescence spectra of 34–Zn2+ (10 μM) with aliquots of 
100 mM phosphoserine in buffer (50 mM HEPES, 100 mM NaCl, pH 7.4). λex = 488 nm. 
λem = 513 nm. Inset is the fit to a binding isotherm. Titrations with phosphoethanolamine 
and glutamate also demonstrated reasonable affinity, though not as high as with 
phosphoserine. The fluorescence increased over 30-fold with the addition of both 
phosphoserine and phosphoethanolamine, with emission at 513 nm when excited at 488 
nm. 
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typical low binding constants seen with monotopic coumarin aldehyde sensors.
102–104 
Presumably, the protonated form of the DPA can interact favorably with the charged 
phosphate to enhance binding. The fluorescence response of sensor 34 was lower without 
Zn
2+
 due to photoinduced electron transfer quenching from the uncoordinated DPA. 
It is clear from the spectroscopic studies of both sensors that 34–Zn2+ is the best 
sensor for phosphoserine both in terms of binding constant and maximum fluorescence 
response (Figure 34). Because of the flexible linker, 34–Zn2+ demonstrated more than 
two orders of magnitude better binding than the more rigid sensor 33. Clearly, the rigid 
structure for 33–Zn2+ prohibits a two-point binding interaction. Even sensor 34 lacking 
Zn
2+
 was a better receptor for phosphoserine than sensor 33. 
 
Figure 34  (a) Binding constants and (b) fluorescence enhancements (Isat/I0) of 
sensors 33 and 34 with phosphoserine. 
 
 
 
Compared to the phospholipid tagging probes, 34–Zn2+ is unique in that it can 
coordinate to the analyte phosphate group and primary amine to achieve selective binding 
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to phosphoserine over other phospholipid head groups. Thus, the head groups 
phosphocholine, α-glycerolphosphate, and D-gluco-pyranose-1-phosphate give no 
response, which is extremely important since the majority of membrane phospholipids 
are choline-based. In addition, 34–Zn2+ is also sensitive to the charge on the head group. 
Phosphoethanolamine and glutamate bind less effectively, as each bears one less negative 
charge than phosphoserine. It should be noted that while glutamate and glycine gave 
enhanced binding and fluorescence output, they are not expressed at high concentrations 
on a cellular membrane. 
 
5.5 Conclusions and Future Directions 
In conclusion, 34–Zn2+ demonstrates a means to selectively sense phosphoserine 
over other major phospholipid head groups by forming a two-point binding interaction 
with the phosphate and primary amine functional groups of the analyte under buffered 
aqueous conditions. Future work in this area will focus on joining this head group 
binding unit to our lipid receptor to produce sensitive and selective sensors for bioactive 
lipids. 
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Chapter 6: Open Molecular Tube Sensor for Oxidized Phospholipids 
 
 
 
6.1 Prior Group Work 
6.1.1 Overview of Molecular Tubes 
 The Glass group has previously reported development of fluorescent 
chemosensors for the detection of saturated lipids.
100,106
 These molecules were built on a 
naphthalene dimer scaffold (Scheme 18). Two molecules of 2,7-dihydroxynaphthalene  
 
Scheme 18  Synthesis and 3D structure of naphthalene dimer scaffold. 
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reacted with the tetramethyl acetal of malonaldehyde to form a rigid, hydrophobic pocket. 
Connecting two of these dimers generated a series of molecules referred to as molecular 
tubes (Figure 35). 
 
Figure 35  General structure of molecular tube. 
 
 
 
 In order to avoid polymerization by reaction of acetals at both hydroxyl groups, 
the general synthesis of these molecular tubes began with alkylation of one hydroxyl. In 
order to provide water solubility for the final sensor it would be convenient to have a 
carboxylic acid at this position, and so alkylation to provide compound 41 was performed 
with ethyl bromoacetate, the ester providing better solubility during synthesis and being 
readily saponified in the final step of the reaction sequence (Scheme 19).  
Acid-catalyzed condensation with tetramethyl malonaldehyde acetal afforded the 
naphthalene dimer 42. From here, electrophilic aromatic substitution resulted in either the  
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Scheme 19  Synthesis of functionalized naphthalene dimers. 
 
 
 
dialdehyde 43 or the dibromide 44, which would allow for a variety of different 
connections to be made between the two naphthalene dimer units. 
 
6.1.2 Amide-Linked Tube 
Molecular modeling indicated that linking the two naphthalene dimers by a three-
atom spacer would provide an inner diameter apporopriate for hosting a saturated alkyl 
chain. Relatively rigid amide and allyl linkers were chosen to enforce an open cavity for 
lipid inclusion. The amide-linked tube was made from two equivalents of the formylated  
naphthalene dimer by oxidation of the aldehyde to a carboxylic acid for one equivalent, 
and reductive amination to the aminomethyl for the second equivalent. A PyBOP  
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coupling of these two products followed by saponification resulted in the full amide-
linked molecular tube 45, which was produced as a mixture of syn- and anti-isomers, 
with respect to the relative orientation of the two naphthalene dimers (Scheme 20). These 
isomers were separated by HPLC and studied independently. 
 
Scheme 20  Synthesis of amide-linked molecular tube. 
 
 
 Both syn- and anti-isomers were capable of binding lipids. They showed very 
little change in their absorbance spectra on lipid binding, but significant changes of 
fluorescence from the naphthalenes was observed. In general, for both tubes, longer fatty 
acids showed increased binding constants, presumably due to increased van der Waals  
interactions over a larger surface. Neutral heptanol had an association constant that was  
fifty times that of hexanoic acid and a twenty-fold increase over octanoic acid, both of  
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which have hydrophobic surfaces similar to that of heptanol but suffer from electrostatic 
repulsion of the negatively charged carboxylates with those on the tube. The importance 
of electrostatics was further demonstrated by the fact that heptylamine, which is 
protonated and positively charged under the titration conditions (pH = 8.4) had a binding 
constant that was approximately eighty times greater than that for octanoic acid. Methyl- 
substituted alkyl chains and unsaturated fatty acids had lower binding constants than their 
straight-chain, saturated counterparts due to steric restrictions for entering the cavity of 
the molecular tube. These results are shown in Table 2 for both the syn- and anti-isomers 
of 45. 
 
Table 2  Binding affinities for long-chain hydrophobic analytes with amide-linked 
molecular tube. 
 
 
 
Syn Tube Anti Tube
Analyte Ka (M
-1
) Ka (M
-1
)
Butyric Acid 17 18
Hexanoic Acid 100 72
Octanoic Acid 250 190
Decanoic Acid 3,500 3,800
Dodecanoic Acid 18,000 27,000
4-Methyloctanoic Acid 71 200
8-Methylnonanoic Acid 1,600 690
1-Heptanol 4,900 6,700
Heptylamine 16,000 16,000
cis -4-Hepten-1-ol 1,200 5,200
trans -3-Octenoic Acid 92 110
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6.1.3 Allyl-Linked Molecular Tubes 
 While the amide-linked tube was relatively rigid due to the resonance of the 
amide bond, there was still a possibility for the tube to bow in on itself, excluding water 
and increasing hydrophobic interactions intramolecularly. If this was the case, the first  
step in binding a lipid would be to re-open the cavity, which has an enthalpic and 
entropic cost that would subsequently lower the association constant for the lipid. In 
order to avoid this problem, a more rigid linker was required. 
 Synthesis of the allyl-linked tube (Scheme 21) began with the brominated 
naphthalene dimer. Stille coupling with tributyl allyl tin afforded the allyl-substituted  
 
Scheme 21  Synthesis of allyl-linked molecular tube. 
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naphthalene dimer, which was then functionalized with a pinacol boronic ester via a 
cross-metathesis reaction. Suzuki coupling with the original brominated naphthalene 
dimer produced the allyl-linked tube, 46, as both the syn- and anti-isomers, which were 
separated by HPLC. 
 Titration results with 46 supported the hypothesis that a more rigid linker provides 
a higher binding affinity. The allyl tube showed association constants of up to 5.9 x 10
5
 
M
-1
 for saturated fatty acids, which means that this sensor should be most sensitive to 
changes in concentration in the low micromolar range. These results are summarized in 
Table 3.  
 
Table 3  Binding affinities for long-chain hydrophobic analytes with allyl-linked 
molecular tube. 
 
 
 
Syn Tube Anti Tube
Analyte Ka (M
-1
) Ka (M
-1
)
Butyric Acid - -
Hexanoic Acid 800 -
Octanoic Acid 17,000 5,400
Decanoic Acid 140,000 120,000
Dodecanoic Acid 590,000 350,000
4-Methyloctanoic Acid 5,200 5,800
8-Methylnonanoic Acid 93,000 12,000
1-Heptanol 420,000 240,000
Heptylamine 2,000,000 8,200,000
cis -4-Hepten-1-ol 39,000 28,000
trans -3-Octenoic Acid 1,300 7,200
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6.2 Open Molecular Tube for the Detection of Oxidized Phospholipids 
6.2.1 Drawbacks to Full Molecular Tubes 
 The molecular tubes discussed in the previous sections both showed excellent 
binding affinity towards aliphatic molecules and selectivity for straight, saturated chains 
over branched and unsaturated chains. The rigid allyl-linked tube was particularly 
effective in binding lipids because it was pre-organized in the open conformation,  
minimizing any entropic penalty for the binding event. Unfortunately, these molecules 
suffered from several disadvantages, including difficulties in synthesis, poor fluorescence 
properties, and difficulty in further modification. 
 The syntheses for the closed tubes involved a macrocyclization near the end of the 
synthetic route. Macrocyclizations often suffer from low yields due to the loss of entropy 
required to close the ring and competition with intermolecular reactions that lead to 
oligomers. A further problem with this particular macrocyclization was the fact that two 
isomers of the tube were formed, syn and anti, which severely restricted the yield of the 
more desirable syn-isomer.  
 The other significant drawbacks to the full tube sensors are due to the naphthalene 
dimers that formed the core of the tube. The naphthalene fluorophores used in the 
molecular tubes showed relatively small changes in fluorescence upon binding lipid. This 
problem was compounded by the fact that the excitation maximum for the fluorophore 
was in the ultraviolet range and the fluorescence was in the violet region, where a number 
of endogenous chromophores and fluorophores absorb and emit in biological samples, 
which would lead to high background signals.  
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 Finally, the naphthalene units were already substituted at four positions, and 
during synthesis, approach from the face of the dimer that was inside the hydrophobic 
cleft was crowded by the adjacent naphthalene. Further modification was hindered by  
these steric interactions, and without such modification it was impossible to develop 
sensors capable of selectivity for one type of saturated lipid over another. Since we were 
interested in developing chemosensors for a number of different types of lipids, including  
phosphatidylserine, cerebrosides, glycolipids, and oxidized phospholipids, it was 
important to have some way of functionalizing the tube with different recognition 
elements for these different analytes. 
 
6.2.2 Benefits of Open Tubes 
 Our approach to overcoming the difficulties with the molecular tubes is shown in 
Figure 36. By making the tube an open structure, we could avoid several problems and 
open up opportunities that were not available with the closed tubes. 
 
Figure 36  General structure of open molecular tube. 
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 The open structure avoids the macrocyclization problem, which limited yield due 
to entropic factors, unwanted oligimerization, and syn-/anti-isomer production. This has  
the possibility to greatly improve yield in the final steps of the synthesis. It also allows 
for different fluorophores to be attached to the naphthalene dimer, giving improved 
fluorescence properties over naphthalene itself. These fluorophores can be constructed  
independently of the dimer core of the tube, allowing for functional groups to be installed 
that can selectively recognize one type of lipid over another, such as boronic acids for 
glycolipid head groups.  
 The main drawback to the open structure is the loss of pre-organization that was 
present in the rigid full tubes. This would likely lead to lower binding constants for the 
aliphatic portion of the lipid, but binding to the second recognition element (R in Figure 
36) by the headgroup or some other portion of the lipid should overcome some of the lost 
association affinity. 
 
6.2.3 Design of Oxidized Phospholipid Sensor 
 The core of the open tubes remained the naphthalene dimer, made in the same 
way as shown in Scheme 19. Carbazole was chosen as the fluorophore due to having 
longer wavelengths of absorbance and emission than naphthalene, an easy method to 
attach it to the core, and the possibility to build a number of carbazoles that are 
functionalized at different positions.  
 For the detection of oxidized phospholipids, a recognition element was required 
that was selective for the aldehyde of the cleaved lipid chain over other, more common  
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functional groups. For this purpose a hydrazide was chosen. Hydrazides and hydrazines  
have been used for the identification of aldehydes and ketones in qualitative organic 
analysis and fluorescent hydrazine derivatives have seen recent use in the detection of 
ketones and aldehydes in biological samples.
107-110
 
 The design and expected sensing mechanism of sensor 47 is shown in Scheme 22. 
While the carbazole hydrazide is unbound, the carbazole’s fluorescence would be 
quenched by photoinduced electron transfer (PET) from the lone pair of the terminal  
 
Scheme 22  Proposed mode of sensing for oxidized phospholipids. 
 
 
 
nitrogen. On encountering an oxidized phospholipid, a hydrazone would be formed 
between the aldehyde and terminal nitrogen of the hydrazide. This would change the 
hybridization of the nitrogen lone pair orbital from sp
3
 to sp
2
, leading to greater stability  
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for the electrons and less propensity to participate in PET quenching. Hydrazone 
formation with an oxidized phospholipid should therefore increase fluorescence intensity 
of the carbazole, and thus 47 was expected to be a turn-on sensor. 
 
6.2.4 Synthesis Carbazole Hydrazide 
 The synthesis of the naphthalene dimer core was identical to that shown in 
Scheme 19, leading to the formylated dimer 43. The carbazole fluorophore was 
synthesized beginning with 4-chloro-3-nitrophenol, which was alkylated with ethyl 
bromoacetate to give 48. A Suzuki coupling with 4-formylphenylboronic acid gave the 
biphenyl 49, which underwent a reductive cyclization with triphenylphosphine to give the 
carbazole 50 in good overall yield (Scheme 23).  
 
Scheme 23  Synthesis of carbazole aldehyde with ethyl ester. 
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 As a proof-of-concept, carbazole hydrazide 53 was synthesized independent of 
the core to test aldehyde recognition (Scheme 24). The carbazole nitrogen was first  
alkylated with 1-iodobutane, followed by oxidation of the aldehyde to 52. A number of 
oxidation conditions were explored. Sodium chlorate led to chlorination of the carbazole 
by electrophilic aromatic substitution. Treatment with Oxone resulted in loss of the  
carbonyl carbon, likely due to Baeyer-Villiger oxidation to the formate ester followed by 
decomposition. Pyridinium dichromate (PDC) provided up to 25% of the product 
carboxylic acid and returned 75% starting material. Chromic acid gave complex 
mixtures. Finally, potassium permanganate in acetone at 0
o
 C afforded product 52 with 
78% yield. The carboxylic acid was converted to hydrazide 53 using an EDC coupling. 
  
Scheme 24  Synthesis of carbazole hydrazide. 
 
 
 Carbazole 53 was titrated with propanal in HEPES buffer at pH 7.4 with 100 mM 
NaCl (Figure 37). Increasing concentration of aldehyde increased the fluorescence of the  
 
67 
 
carbazole, as expected. The binding constant was relatively weak (3.9 M
-1
), but in the full  
sensor the main contribution to binding will come from the hydrophobic effect between 
the saturated alkyl chain of the lipid and the interior of the open tube. Once the lipid 
chain is bound, the high effective concentration of aldehyde near the sensor will ensure 
formation of the hydrazone and cause a change in fluorescence. 
 
Figure 37  Fluorescence titration of 53 with propanal in HEPES buffer. 
 
 
 
6.2.5 Synthesis of Open Tube 
 In order to connect the carbazole to the core, the formylated naphthalene dimer 
was reduced to the alcohol with sodium borohydride, followed by substitution to the 
benzyl bromide with phosphorus tribromide (Scheme 25). Nucleophilic substitution by  
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Scheme 25  Synthesis of open molecular tube 56. 
 
 
 
carbazole on the bromomethyl core was done using lithium bis(trimethylsilyl)amide 
(LiHMDS) to afford the open tube 56. 
Oxidation of the open tube aldehyde was attempted, but only returned starting 
material due to its poor solubility. The open tube with ethyl esters was not readily 
dissolved in any solvents explored except DMF and DMSO. Due to the difficulty of 
working with compounds with low solubility, the synthesis was restarted with hexyl  
esters instead of ethyl esters on both the naphthalene and the carbazole (Scheme 26 and 
Scheme 27). 
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Scheme 26  Synthesis of carbazole aldehyde with hexyl ester. 
 
 
 
The hexyl ester compounds showed increased solubility in organic solvents at 
every stage of the synthesis. Unfortunately, once the carbazole was attached to the 
naphthalene core to form 65, the solubility of the resulting open tube was still poor in  
most solvents. Reaction with potassium permanganate in acetone at 0
o
 C still resulted in 
only returned starting material due to poor solubility of the open tube. Attempting the 
reaction at room temperature, where the solubility of the open tube was still very low, 
resulted in a complex mixture of oxidation products.   
 
 
70 
 
Scheme 27  Synthesis of open molecular tube 65. 
 
 
 Due to the difficulty in oxidizing the open tube aldehyde 65, we attempted to 
make the hydrazone instead of the hydrazide to determine if it could perform as a sensor 
for oxidized phospholipids by generating the dihydrazone. To this end, the esters of 65 
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were converted to the carboxylic acids by saponification, and the resulting tetracarboxylic 
acid was treated with a large excess of hydrazine hydrate to produce the final sensor, 67 
(Scheme 28). 
 
Scheme 28  Synthesis of hydrazone-functionalized open molecular tube. 
 
 
 
Titrations of 67 were performed with hexanal in citrate buffer. The results of our 
titrations can be seen in Figure 38. The fluorescence band at 393 nm decreased and a new 
band appeared at 450 nm as the concentration of hexanal was increased. The titrations  
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Figure 38  Fluorescence titration of 67 with hexanal in citrate buffer. 
 
 
 
were performed at the relatively low pH of 5.5 due to the fact that hydrazone formation is 
significantly more favorable at this pH. Others have reported virtually no hydrazone 
formation at neutral pH when attempting to conjugate fluorophores onto 
biomolecules.
108,110
 
The results fit a binding isotherm with an equilibrium constant of 51 M
-1
. By 
comparison, the full, rigid allyl-linked tube had a binding constant for hexanoic acid of 
800 M
-1
,
 
and the less rigid amide-linked tube had a binding constant of 100 M
-1
. Our  
result was in line with this data, as the lipid binding would be expected to be weaker in 
the open tube due to the reduced degree of pre-organization/greater degree of freedom in 
the open carbazole arms. Further experiments on 67 were performed with decanal, but  
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due to its very low solubility in water no reliable data could be gathered. Titrations were 
also performed in 10% DMSO/citrate buffer at pH 5.5 (Figure 39), which demonstrated a 
significantly lower association constant of 11 M
-1
, indicating the importance of the 
hydrophobic interaction to the binding affinity of the open tube for aliphatic aldehydes. 
 
Figure 39  Fluorescence titration of 67 with hexanal in 10% DMSO/citrate buffer. 
 
 
 
Due to the short chain length of hexanal, it was possible that the majority of the 
molecule was buried inside the hydrophobic cavity and there was relatively little 
interaction between the aldehyde and hydrazone. To explore this possibility, we 
synthesized the succinic dihydrazide hydrazone by reaction of the saponified open tube 
aldehyde with a large excess of succinic dihydrazide in DMSO (Scheme 29). The  
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Scheme 29  Synthesis of succinic dihydrazide hydrazone open molecular tube 68. 
 
 
 
hypothesis was that the flexible linker now present between the fluorophore and terminal 
hydrazide nitrogen would allow the short hexanal to maximize its hydrophobic 
interaction inside the cavity while maintaining contact with the hydrazide, which could 
bend around towards the hydrophobic cavity, in order to form the new hydrazone. 
Unfortunately, the dihydrazide hydrazone sensor, while stable on its own in buffer, was 
not photostable in the presence of hexanal, and so no reliable data could be gathered.  
 
6.3 Conclusions and Future Directions  
The titration results for the open molecular tube hydrazone 67 show promise for 
the use of hydrazide- and hydrazone-bearing molecular tubes for the recognition of 
oxidized phospholipids. Future work on this project will include further attempts at  
oxidizing the aldehyde-bearing open molecular tube to the dicarboxylic acid in order to 
generate the original proposed sensor 47. We will also attempt to create a protected 
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carbazole hydrazide, 69 (Figure 40), to attach to the naphthalene dimer core, followed by 
deprotection of hydrazide and esters to give the original target sensor 47. In addition, we 
are also exploring alternative ways to attach hydrazines or hydrazides to the carbazole 
arm, as well as other possible fluorophores that would still promote binding. 
 
Figure 40  Carbazole ester with alloc protecting group. 
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APPENDIX 
 
 
EXPERIMENTAL PROCEDURES 
 
 
Instrumentation 
Absorption spectra were recorded on a Cary 1E spectrophotometer at 25 °C. 
Fluorescence spectra were recorded on a Shimadzu RF-5301 PC spectrofluorometer at 25 
°C. NMR spectra were recorded on Bruker DRX 500 or Bruker DRX 300.  
 
Solution preparation: Phosphoserine Sensors 
 Solutions for UV/Vis and fluorescence spectroscopy were prepared from a 1 mg mL
−1
 
sensor stock solution in MeOH that was diluted to volume with buffer (50 mM HEPES, 
100 mM NaCl, pH 7.4) until a 10 μM sensor solution was produced following removal of 
the solvent. For sensor 1, DMSO was added to equal 3% of the total volume to improve 
solubility. Analytes were measured and diluted to volume with the buffered sensor 
solution to keep the sensor concentration constant throughout the titration. 
 
Solution preparation: Oxidized Phospholipid Sensors 
Solutions for UV/Vis and fluorescence spectroscopy were prepared from a 1 mg mL
−1
 
sensor stock solution in DMSO that was diluted to volume with buffer (10 mM citrate, no 
salt, pH 5.5) until a 10 μM sensor solution was produced following removal of the 
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solvent. Analytes were measured by volume and diluted to volume with the buffered 
sensor solution to keep the sensor concentration constant throughout the titration. 
 
Quantum yields 
Separate stock solutions of sensors 1 and 2 (10 μM) in buffer (50 mM HEPES, 100 mM 
NaCl, pH 7.4) were prepared. The solution of sensor 1 contained 3% (v/v) DMSO as a 
cosolvent. For quantum yields (Φfl), a 1.0 μM solution of fluorescein (absolute Φfl = 0.85) 
in 0.1 N NaOH (pH 13) was used as a fluorescence standard. Sensors 1 and 2 were 
excited at 473 nm. The slit width was 2 nm for both excitation and emission. Quantum 
yields were obtained in triplicate. 
 
Binding constant calculations 
The concentration of analyte was plotted against the fluorescence intensity and fit to a 
one-site binding isotherm. 
 
Synthetic procedures 
General methods 
All reactions were carried out in dried glassware under a blanket of N2. Before use, 
tetrahydrofuran and diethyl ether were distilled from sodium benzophenone ketyl while 
dichloromethane and triethylamine were distilled from CaH2. NMR spectra were 
recorded on Bruker DRX 500 or Bruker DRX 300. IR spectra were recorded on a Nexus 
670 FT-IR E.S.P. 
spectrometer. 
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Materials 
All chemicals were obtained from Sigma Aldrich, Fisher Scientific, Combi-Blocks, TCI 
America, or Alfa Aesar and were used without further purification. Flash 
chromatography was performed with 32–63 μm silica gel obtained from Dynamic 
Adsorbents.  
 
 
 
Compound 30: 
2,6-Diaminopyridine (10.0 g, 91.6 mmol) and d,l-malic acid (13.5 g, 100.8 mmol) were 
added to a flask and cooled to 0 °C.  Concentrated sulfuric acid (50 mL) was added and 
the mixture was warmed to room temperature, then heated to 120 °C under N2 for 2.5 
hours. The mixture was poured over ice and made basic with saturated ammonium 
hydroxide to pH 8, then filtered and rinsed with water. The reaction consistently 
produced naphthyridine 30 in greater than 90% yield. 
1
H NMR (300 MHz, CDCl3): δ 11.5 ppm (s, 1H), 7.61 ppm (d, J = 9.3 Hz, 2H), 6.73 
ppm (s, 2H), 6.31 ppm (d, J = 8.5 Hz, 1H), 6.08 ppm (d, J = 9.2 Hz, 1H). 
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Compound 31: 
Naphthyridine 30 (14.67 g, 91.03 mmol) and sodium nitrite (10.345 g, 149.9 mmol) were 
dissolved in concentrated sulfuric acid (150 mL) and stirred at room temperature for 10 
minutes. The mixture was poured over ice and stirred for another 20 minutes. The 
reaction was made basic with sodium hydroxide (10M solution), then acidified to pH 5 
with glacial acetic acid. Product was filtered and rinsed with water, followed by ethanol, 
and then dried under vacuum to afford diol 31 (12.59 g, 77.7 mmol, 85.3% yield). 
1
H NMR (300 MHz, CDCl3): δ 11.6 ppm (s, 2H), 7.81 ppm (d, J = 9.0 Hz, 2H), 6.34 
ppm (d, J = 9.0 Hz, 2H). 
 
 
 
 
 
Compound 32: 
Compound 31 (5.2886 g, 32.81 mmol), phosphorus pentachloride (13.53 g, 64.97 mmol),  
and phosphorus oxychloride (6.88 mL) were added to a flask and refluxed for 2 hours. 
After cooling to room temperature, the mixture was poured over ice and neutralized with 
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sodium bicarbonate, then potassium carbonate until pH 8. The mixture was filtered, and 
the solid was recrystalized from acetone to give dichloride 32 as a brown solid (2.8934 g, 
14.54 mmol, 44.3% yield). 
1
H NMR (300 MHz, CDCl3): δ 8.16 ppm (d, J = 8.5 Hz, 2H), 7.54 ppm (d, J = 8.5 Hz, 
2H) 
 
 
 
 
 
Compound 27: 
In a flame-dried flask, compound 32 (125 mg, 0.628 mmol), 4-methoxyaniline (154.7 
mg, 1.256 mmol), bis(diphenylphosphino)propane (62.15 mg, 0.151 mmol), 
tris(dibenzylideneacetone)dipalladium (69.00 mg, 0.0753 mmol), and cesium carbonate 
(1.023 g, 3.136 mmol) were dissolved in dimethylformamide (30 mL). The system was 
flushed with N2 and degassed by bubbling N2 through the solution for 1 hour. In a 
separate flame-dried flask, more compound 32 (125 mg, 0.628 mmol) was dissolved in 
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DMF (30 mL) and degassed as before. The first flask was then heated to 110 °C under 
N2. After six hours, the second solution was slowly added by syringe pump over 18 
hours. Heating continued for another 36 hours after the last of the solution was added. 
The DMF was removed under reduced pressure. The product was dissolved in 
dichloromethane and filtered through a basic alumina plug. HPLC was performed using 
an acetonitrile/water solvent system with 0.5% trifluoroacetic acid. The eluted product 
was dissolved in dichloromethane and washed with saturated sodium bicarbonate to 
remove trifluoroacetic acid. The organic layer was dried with sodium sulfate and filtered, 
and the dichloromethane was removed under reduced pressure to afford 27 (0.0312 g, 
.0313 mmol, 9.97% yield).  
1
H NMR (250 MHz, CDCl3): δ 8.13 ppm (d, J = 7.5 Hz, 8H), 7.32 ppm (d, J = 8.1 Hz, 
8H), 7.07 ppm (d, J = 7.0 Hz, 8H), 6.97 ppm (d, J = 8.0 Hz, 8H), 3.82 ppm (s, 12H). 
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Compound 36 
Compound 35 (250 mg, 1.072 mmol), Na2CO3 (340 mg, 3.215 mmol), and TsCl (204.4 
mg, 1.072 mmol) were dissolved in 10 mL degassed DMF–H2O (95 : 5). The solution 
was stirred at 60 °C for 1 h. Then 4-(hydroxymethyl)phenylboronic acid (179.2 mg, 
1.179 mmol) and PdCl2 (29 mg, 0.161 mmol) were added and N2 was bubbled through 
for 5 min. The solution was stirred at 60 °C for 16 h. The inorganic solids were filtered 
off and rinsed with acetone. The solvent was removed in vacuo and the remaining crude 
material was purified by chromatography (95 : 5 CH2Cl2–EtOAc) to yield compound 36 
(156.5 mg, 45%) as a yellow solid (mp 62 °C): 
 
1
H NMR (500 MHz, CDCl3) δ 7.50 (d, 2H, J = 7.5 Hz), 7.43 (d, 2H, J = 7.5 Hz), 7.23 (d, 
1H, J = 9.0 Hz), 6.57 (d, 1H, J = 2.0 Hz), 6.51 (dd, 1H, J = 9.0, 2.0 Hz), 5.99 (s, 2H), 4.80 
(s, 2H), 3.42 (q, 4H, J = 7.0), 1.21 (t, 6H, 7.0 Hz); 
13
C NMR (125 MHz, CDC
l3) δ 162.1, 
156.8, 155.8, 150.6, 142.1, 135.5, 128.6, 127.8, 127.1, 108.5, 108.2, 107.9, 97.9, 64.8, 
44.8, 12.4; IR (neat, cm
−1
) 3412, 2970, 1695, 1605, 1589, 1417, 1352, 1115; HRMS 
calculated for C20H21NO3Na (M + Na
+
): 346.1414. Found: 346.1414.  
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Compound 37  
Compound 36 (100 mg, 0.309 mmol) and POCl3 (3 mL) were combined in a round 
bottom flask and stirred at room temperature for 21 h. The mixture was poured 
over ice water (10 mL) and extracted with CH2Cl2 (10 mL × 4). The organic solvent was 
removed in vacuo and the resulting material was purified by chromatography (90 : 10 
CH2Cl2–EtOAc) to yield compound 37 (81 mg, 77%) as a yellow oil: 
1
H NMR (500 
MHz, CDCl3) δ 7.51 (d, 2H, J = 8.0 Hz), 7.43 (d, 2H, J = 8.0 Hz), 7.22 (d, 1H, J = 9.0 
Hz), 6.56 (d, 1H, J = 2.5 Hz), 6.51 (dd, 1H, J = 9.0, 2.5 Hz), 5.98 (s, 1H), 3.41 (q, 4H, J = 
7.0 Hz), 1.20 (t, 6H, J = 7.0 Hz); 
13
C NMR (125 MHz, CDCl3) δ 161.9, 156.7, 155.4, 
150.6, 138.5, 136.3, 128.8, 128.7, 127.7, 108.5, 108.3, 107.6, 97.8, 45.6, 44.7, 12.4; IR 
(neat, cm
−1
) 2970, 1708, 1614, 1593, 1524, 1417, 1356, 1115; HRMS calculated for 
C20H20ClNO2Na (M + Na
+
): 364.1075. Found: 364.1077.  
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Compound 38 
The Vilsmeier reagent was made by combining 2 mL POCl3 and 3.6 mL DMF in a flame-
dried round bottom flask at 0 °C and stirring for 30 min. In a separate 
flask, 143 mg of compound 37 (2.59 mmol) was dissolved in 3 mL DMF. The starting 
material was cooled to 0 °C and 3 mL of the Vilsmeier reagent was added dropwise. The 
reaction was brought to room temperature and stirred for 40 h. The mixture was poured 
over ice water (30 mL), extracted with CH2Cl2 (20 mL × 6), the organic layers combined 
and dried over Na2SO4, and the solvent removed in vacuo. Purification via column 
chromatography (95 : 5 CH2Cl2–EtOAc) yielded compound 38 as a yellow oil (97 mg, 
62%): 
1
H NMR (500 MHz, CDCl3) δ 9.89 (s, 1H), 7.54 (d, 2H, J = 8.0 Hz), 7.26 (d, 2H, 
J = 8.0 Hz), 6.94 (d, 1H, J = 9.5 Hz), 6.49–6.53 (m, 2H), 4.68 (s, 2H), 3.45 (q, 4H, J = 7.0 
Hz), 1.23 (t, 6H, J = 7.0 Hz); 
13
C NMR (125 MHz, CDCl3) δ 188.2, 160.8, 160.1, 157.7, 
153.1, 138.3, 133.4, 131.0, 128.6, 128.5, 112.0, 109.8, 108.9, 97.0, 45.7, 45.2, 12.4; IR 
(neat, cm
−1
) 1614, 1559, 1494, 1417, 1352; HRMS calculated for C21H20ClNO3Na (M + 
Na
+
): 392.1024. Found: 392.1022. 
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Compound 33 
Compound 38 (102 mg, 0.276 mmol), di(2-picolyl)amine (55 μL, 0.290 mmol), K2CO3 
(114 mg, 0.828 mmol), and 7 mL of THF were combined in a round bottom flask and 
stirred at 55 °C for 21 h. The mixture was filtered and rinsed with acetone. The filtrate 
solvent was removed in vacuo and the remaining residue was purified via column 
chromatography (100% CH2Cl2 → 100% EtOAc → 80 : 20 EtOAc–MeOH) to yield 
sensor 33 as a yellow oil (54 mg, 47%). 
1
H NMR (500 MHz, CDCl3) δ 9.76 (s, 1H) 8.55 
(d, 2H, J = 5.0 Hz), 7.69 (td, 2H, J = 7.5, 1.5 Hz), 7.61 (d, 2H, J = 8.0 Hz), 7.54 (d, 2H, J 
= 8.0 Hz), 7.21 (d, 2H, J = 8.0 Hz), 7.17 (m, 2H), 6.93 (d, 1H, J = 9.5 Hz), 6.45–6.51 (m, 
2H), 3.88 (s, 4H), 3.80 (s, 2H), 3.43 (q, 4H, J = 7.0 Hz), 1.21 (t, 6H, J = 7.0 Hz); 
13
C 
NMR (125 MHz, CDCl3) δ 188.3, 162.2, 159.5, 159.4, 157.7, 153.0, 148.9, 140.2, 136.5, 
131.5, 130.9, 128.7, 128.5, 122.8, 122.0, 112.2, 109.6, 108.9, 96.9, 60.1, 58.1, 45.1, 12.4; 
IR (neat, cm
−1
) 1746, 1611, 1495, 1422, 1356, 1133, 731; HRMS calculated for 
C33H32N4O3Na (M + Na
+
): 555.2367. Found: 555.2366. 
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Compound 40 
Compound 39 (0.0412 g, 0.1358 mmol), iodine (0.0655 g, 0.2580 mmol), 
triphenylphosphine (0.0641 g, 0.2444 mmol) and imidazole (0.0185 g, 0.2716 mmol) 
were dissolved in dichloromethane (7.0 mL) and stirred at room temperature for 2 h. The 
mixture was filtered and column chromatography was performed twice on silica with 9 : 
1 CH2Cl2–EtOAc to give compound 40 (48.9 mg, 90%) as a yellow solid (decomp 138–
141 °C). 
1
H NMR (300 MHz, CDCl3) δ 10.35 (s, 1H), 7.73 (d, 1H, J = 9.6 Hz), 6.69 (dd, 
1H, J = 9.3, 4.5 Hz), 6.47 (d, 1H, J = 2.7 Hz), 3.33–3.52 (m, 8H), 2.05–2.15 (m, 2H), 
1.26 (t, 6H, J = 4.2 Hz); 
13
C NMR (75 MHz, CDCl3) δ 190.9, 162.9, 161.5, 157.6, 152.8, 
128.6, 111.8, 110.1, 108.4, 97.3, 45.1, 33.5, 28.9, 12.5, 6.8; IR (neat, cm
−1
) 2913, 1716, 
1671, 1614, 1556, 1503, 1454, 1352; HRMS calculated for C17H20INO3Na (M + Na
+
): 
436.0380. Found: 436.0372.  
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Compound 34 
In a flame-dried flask, compound 40 (0.0485 g, 0.1174 mmol), potassium carbonate 
(0.0243 g, 0.1761 mmol), and di(2-picolyl)amine (31.7 μL, 0.1761 mmol) were dissolved 
in acetonitrile (4.1 mL) and the flask was flushed with N2. The mixture was stirred at 
room temperature for 60 h. Column chromatography on silica with 1 : 1 CH2Cl2–EtOAc 
gave sensor 34 (24.1 mg, 56%) as a yellow solid (mp 109 °C). 
1
H NMR (300 MHz, 
CDCl3) δ 10.34 (s, 1H), 8.55 (d, 2H, J = 4.2 Hz), 7.56–7.71 (m, 5H), 7.14–7.19 (m, 2H), 
6.52 (dd, 1H, J = 5.7, 2.7 Hz), 6.44 (d, 1H, J = 2.7 Hz); 
13
C NMR (75 MHz, CDCl3) δ 
190.7, 163.8, 163.1, 159.6, 157.5, 152.6, 149.0, 136.4, 128.7, 123.0, 121.9, 111.7, 109.8, 
108.5, 97.2, 60.2, 54.3, 45.0, 27.8, 25.8, 12.4; IR (neat, cm
−1
) 2970, 2921, 1712, 1676, 
1615, 1559, 1508, 1452, 1355, 1148, 1131; HRMS calculated for C29H32N4O3Na (M + 
Na
+
): 507.2367. Found: 507.2357. 
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Compound 51 
In a flame-dried flask, compound 50 (0.0422 g, 0.142 mmol), sodium hydride (60% by 
mass, suspended in mineral oil, 0.0057 g, 0.142 mmol), and 5 mL DMF were mixed and 
the flask was flushed with N2. After 30 minutes, 1-iodobutane (32.3 μL, 0.284 mmol) 
was added via syringe and the mixture was stirred at room temperature for 12 hours. The 
flask was then cooled to 0
 
°C and the reaction was quenched with saturated ammonium 
chloride solution. Extraction with CH2Cl2 followed by column chromatography on silica 
with 100% CH2Cl2 gave compound 51 (45.9 mg, 92%) as a yellow solid (mp 108-111 
°C). 
1
H NMR (300 MHz, CDCl3) δ 10.10 (s, 1H), 8.04 (d, 1H, J = 7.8 Hz), 7.98 (d, 1H, J 
= 9.3 Hz), 7.86 (s, 1H), 7.68 (d, 1H, J = 7.8 Hz), 6.85-6.88 (m, 2H), 4.74 (s, 2H), 4.20-
4.34 (m, 4H), 1.81 (m, 2H), 1.25-1.44 (m, 5H), 0.93 (t, 3H, J = 7.4); 
13
C NMR (75 MHz, 
CDCl3) δ; 192.0, 168.8, 158.5, 143.5, 140.3, 132.9, 128.2, 122.4, 121.8, 119.6, 116.7, 
109.1, 108.2, 94.7, 65.9, 61.4, 43.0, 30.9, 20.5, 14.2, 13.8; IR (neat, cm
−1
) 2954, 2929, 
2868, 1753, 1671, 1622, 1434, 1160. 
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Compound 52 
Compound 51 (29.2 mg, 0.826 mmol) was dissolved in 0.5 mL of acetone in a 2 mL vial 
and cooled to 0
 
°C. Potassium permanganate (19.6 mg, 0.124 mmol) was added to the 
vial and rinsed down with another 0.5 mL of acetone. The reaction was stirred at 0
 
°C for 
4 hours, then diluted with ethyl acetate and washed with a 10% aqueous solution of acetic 
acid. The organic phase was dried with sodium sulfate and filtered to give Compound 52 
(23.9 mg, 78%) as a pale yellow solid (decomp 171 °C).
 1
H NMR (300 MHz, CDCl3) δ 
8.17 (s, 1H), 7.98-8.06 (m, 3H), 6.88-6.93 (m, 2H), 4.77 (s, 1H), 4.28-4.35 (m, 4H), 1.84 
(m, 2H), 1.38-1.46 (m, 2H), 1.33 (t, 3H, J = 7.2), 0.97 (t, 3H, J = 7.4); 
13
C NMR (75 
MHz, CDCl3) δ 173.1, 169.0, 158.2, 143.2, 140.0, 127.4, 125.1, 122.2, 121.0, 119.2, 
116.9, 110.9, 108.0, 94.7, 66.0, 61.5, 43.0, 31.0, 20.5, 14.2, 13.9; IR (neat, cm
−1
) 3432, 
2954, 2925, 2848, 1752, 1646, 1601, 1385, 1197, 1070. 
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Compound 53 
Compound 52 (22.2 mg, 0.0601 mmol), EDC (17.2 mg, 0.0901 mmol) and 
dimethylaminopyridine (11.0 mg, 0.0901 mmol) were dissolved in 3 mL of 
dichloromethane and cooled to 0
 °C for 1.5 hours. Anhydrous hydrazine (3.0 μL, 0.0721 
mmol) was added and the reaction was stirred for 1 hour at 0
 
°C. The mixture was 
washed with brine, dried with sodium sulfate and filtered through a plug of silica with 1:1 
CH2Cl2/EtOAc to provide compound 53 (6.4 mg, 28%) as an off-white solid. 
1
H NMR (500 MHz, CDCl3) δ 7.97-8.01 (m, 2H), 7.94 (s, 1H), 7.69 (dd, 1H, J = 1.3, 8.3 
Hz), 6.88-6.90 (m, 2H), 4.76 (s, 2H), 4.32 (q, 2H, J = 7.2 Hz), 4.17 (t, 2H, J = 7.3), 1.77-
1.83 (m, 2H), 1.30-1.41 (m, 5H), 0.92 (t, 3H, J = 7.3). 
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Compound 57 
4-Chloro-3-nitropenol (778 mg, 4.482 mmol), hexyl bromoacetate (1.500 g, 6.723 mmol) 
and 40 mL DMF were combined in a round bottom flask and stirred at room temperature. 
Potassium carbonate (929 mg, 6.723 mmol) was added and the flask was flushed with N2. 
After 14 hours the majority of the DMF was removed under reduced pressure, the 
mixture was dissolved in CH2Cl2 and extracted with 10% HCl. Column chromatography 
on silica gel with 1:1 hexanes:CH2Cl2 gave compound 57 (1.29 g, 91%) as a yellow oil. 
1
H NMR (300 MHz, CDCl3) δ 7.45 (d, 1H, J = 9.0), 7.40 (d, 1H, J = 3.0), 7.10 (dd, 1H, J 
= 3.0, 9.0), 4.68 (s, 2H), 4.21 (t, 2H, J = 6.8), 1.61-1.70 (m, 2H), 1.29-1.33 (m, 6H), 0.90 
(m, 3H); 
13
C NMR (75 MHz, CDCl3) δ 167.7, 156.6, 148.0, 132.5, 120.3, 119.3, 111.5, 
65.9, 65.6, 31.2, 28.4, 25.4, 22.4, 13.9; IR (neat, cm
−1
) 3536, 3093, 2958, 2925, 2852, 
1748, 1536, 1482, 1352, 1307, 1201, 1078, 805; HRMS calculated for C14H18ClNO5Na 
(M + Na
+
): 338.07657. Found: 338.07656. 
. 
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Compound 58 
Compound 57 (320 mg, 1.02 mmol), 4-formylphenylboronic acid (244 mg, 1.63 mmol), 
tris(dibenzylideneacetone)dipalladium (27.9 mg, 0.0305 mmol), SPhos (56.7 mg, 0.138 
mmol), and cesium fluoride (401 mg, 2.64 mmol) were added to a sealed tube capped 
with a rubber septum, evacuated and back-filled with N2. THF (14 mL) was added by 
syringe and the tube was sealed with a screw cap. The mixture was heated at 100 °C for 
46 hours, cooled to room temperature and filtered through a silica plug, which was then 
rinsed with 20% diethyl ether in dichloromethane. The resulting solution was dried under 
reduced pressure and column chromotography was performed  on silica with DCM to 
yield compound 58 (284 mg, 73%) as an orange oil. 
1
H NMR (500 MHz, CDCl3) δ 10.09 
(s, 1H), 7.95 (d, 2H, J = 8.0 Hz), 7.49 (d, 1H, J = 2.5), 7.47 (d, 2H, J = 8.0), 7.39 (d, 1H, J 
= 8.5 Hz), 7.24 (dd, 1H, J = 2.5, 8.5 Hz), 4.77 (s, 2H), 4.27 (t, 2H, J = 6.8 Hz), 1.69-1.72 
(m, 2H), 1.33-1.37 (m, 6H), 0.92 (t, 3H, J = 7 Hz). 
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Compound 59 
Compound 58 (269 mg, 0.698 mmol), and triphenylphosphine (458 mg, 1.74 mmol) were 
dissolved in 7 mL of o-dichlorobenzene. The flask was fitted with a condenser and the 
system flushed with N2. The mixture was heated at reflux for 16 hours, cooled to room 
temperature and poured directly onto a silica gel column and chromatographed with 0 to 
5% diethyl ether:dichloromethane to afford compound 59 (221 mg, 90%) as a pale yellow 
solid (mp 114-116 °C).  
1
H NMR (500 MHz, CDCl3) δ 10.08 (s, 1H), 8.54 (s, 1H), 8.05 
(d, 1H, J = 8.0 Hz), 7.96 (d, 1H, J = 8.5), 7.91 (s, 1H), 7.72 (d, 1H, J = 8.0), 6.89-6.93 (m, 
2H), 4.73 (s, 2H), 4.23 (t, 2H, J = 6.8), 1.62-1.68 (m, 2H), 1.21-1.33 (m, 6H), 0.84 (t, 3H, 
J = 7.0 Hz); 
13
C NMR (75 MHz, CDCl3) δ 192.4, 169.0, 158.4, 142.5, 139.2, 133.1, 
128.6, 122.3, 122.0, 119.6, 117.0111.4, 109.3, 95.9, 65.7, 65.6, 31.2, 28.4,25.3, 22.4, 
13.8; IR (neat, cm
−1
) 3346, 2950, 2925, 2852, 1740, 1687, 1626, 1467, 1426, 1307, 1234, 
1189, 792; HRMS calculated for C21H23NO4Na (M + Na
+
): 376.15193. Found: 
376.15185. 
. 
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Compound 60 
2,6-Dihydroxynaphthalene (3.00 g, 18.7 mmol) and sodium hydride (60% by mass, 
suspended in mineral oil, 644 mg, 16.1 mmol) were dissolved in 90 mL DMF and the 
flask was flushed with N2 for 30 minutes. Hexyl bromoacetate was added by syringe and 
the mixture was stirred at room temperature for 10 hours. DMF was removed under 
reduced pressure and column chromatography was performed on silica gel with 0 to 3% 
diethyl ether in dichloromethane to afford compound 60 (1.43 g, 25%) as brown solid 
(mp 83-86 °C). 
1
H NMR (300 MHz, CDCl3) δ 7.47-7.55 (m, 2H), 7.14 (dd, 1H, J = 2.4, 
9.0), 7.04-7.08 (m, 2H), 7.00 (d, 1H, J = 2.4), 5.93 (s, 1H), 4.72 (s, 2H), 4.23 (t, 2H, J = 
6.8), 1.60-1.69 (m, 2H), 1.24-1.35 (m, 6H), 0.85 (t, 3H, J = 6.4 Hz); 
13
C NMR (75 MHz, 
CDCl3) δ 169.7, 154.1, 152.4, 130.4, 129.2, 128.4, 128.1, 119.0, 118.4, 109.7, 107.4, 
65.7, 65.5, 31.3, 28.5, 25.4, 22.5, 13.9; IR (neat, cm
−1
) 3407, 2954, 2925, 2852, 1736, 
1605, 1511, 1393, 1213, 1111, 1066, 850; HRMS calculated for C18H22O4Na (M + Na
+
): 
325.14103. Found: 325.14111. 
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Compound 61 
Compound 60 (1.43 g, 4.73 mmol) was dissolved in 11 mL of nitromethane and 4 mL of 
dichloromethane and flushed with N2. 4 mL trifluoroacetic acid was added by syringe, 
then 470 μL of 1,1,3,3-tetramethoxypropane was added dropwise over 30 minutes. The 
solution was stirred at room temperature for 6 hours. Ice was added to the flask, followed 
by saturated sodium bicarbonate solution until a pH of 8 was reached. The product was 
extracted from the mixture with dichloromethane, dried over sodium sulfate, filtered and 
then purified by column chromatography on silica in DCM to yield compound 61 (1.09 g, 
72%) as a yellow solid (mp 85 °C).  
1
H NMR (300 MHz, CDCl3) δ 8.40 (d, 2H, J = 9.3), 
7.39 (d, 2H, J = 8.7), 7.28 (dd, 2H, J = 2.7, 9.3), 7.08 (d, 2H, J = 9.0), 6.95 (d, 2H, J = 
2.7), 6.19 (s, 1H), 5.15 (s, 1H), 4.64 (s, 4H), 4.17 (t, 4H, J = 6.6), 2.31 (s, 2H), 1.56-1.77 
(m, 4H), 1.20-1.28 (m, 12H), .79-.88 (m, 6H); 
13
C NMR (75 MHz, CDCl3) δ 169.0, 
154.0, 148.9, 130.4, 127.3, 126.8, 124.4, 119.0, 118.7, 118.4, 108.6, 91.4, 65.5, 65.4, 
31.3, 28.5, 26.7, 25.4, 22.8, 22.4, 13.9; IR (neat, cm
−1
) 2958, 2929, 2868,1753, 1671, 
1626, 1454, 1172; HRMS calculated for C39H44O8Na (M + Na
+
):663.29294. Found: 
663.29210.  
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Compound 62 
Compound 61 (4.28 g, 6.68 mmol) and 1,1-dichloromethyl methyl ether (2.4 mL, 27 
mmol) were dissolved in 75 mL of dichloromethane and the flask was flushed with 
nitrogen gas and cooled to 0 °C. 27 mL of a 1.0 M solution of TiCl4 was added via 
syringe and the mixture was stirred at 0 °C for 15 hours while slowly warming to room 
temperature. The reaction mixture was cooled to 0 °C and quenched with a saturated 
solution of sodium bicarbonate. The mixture was extracted with DCM, dried over 
Na2SO4, and columned in 0 to 3% diethyl ether in DCM to yield compound 62 (4.09 g, 
88%) as a yellow solid (decomp 102 °C).  
1
H NMR (300 MHz, CDCl3) δ 10.84 (s, 2H), 
9.03 (d, 2H, J = 9.6), 8.57 (d, 2H, J = 9.6), 7.25 (d, 2H, J = 8.4), 7.16 (d, 2H, J = 9.6), 
6.22 (s, 1H), 5.14 (s, 1H), 4.79 (s, 4H), 4.17 (t, 4H, J = 6.9), 2.37 (s, 2H), 1.55-1.64 (m, 
4H), 1.18-1.27 (m, 12H), .079-.083 (m, 6H); 
13
C NMR (75 MHz, CDCl3) δ 191.9, 168.3, 
160.0, 149.5, 130.6, 127.6, 126.7, 125.5, 122.0, 118.4, 113.5, 91.1, 66.4, 65.8, 31.2, 28.4, 
26.6, 25.4, 22.7, 22.4, 13.9; IR (neat, cm
−1
) 2958, 2929, 2860, 1748, 1675, 1589, 1524, 
1385, 1201, 1054, 907, 817; HRMS calculated for C41H44O10Na (M + Na
+
): 719.28267. 
Found: 719.28190. 
 
107 
 
 
 
108 
 
 
Compound 63 
Compound 62 (1.67 g, 2.39 mmol) was dissolved in 40 mL THF and 40 mL 1-hexanol 
and cooled to 0 °C. NaBH4 (226 mg, 5.98 mmol) was added and the mixture was stirred 
at 0 °C for 25 minutes, then quenched at 0 °C with a saturated solution of NH4Cl and 
warmed to room temperature. The product was extracted with DCM, dried over Na2SO4 
and filtered, and then purified by column chromatography on silica with 0-30% 
Et2O/DCM to yield compound 63 (1.05 g, 62%) as a yellow-brown solid. 
1
H NMR (300 
MHz, CDCl3) δ 8.49 (d, 2H, J = 9.3), 7.99 (d, 2H, J = 9.2 Hz), 7.22-7.26 (m, 4H), 6.27 (s, 
1H), 5.28 (s, 1H), 5.10-5.15 (m, 4H), 4.81 (d, 4H, J = 4.8), 4.14 (t, 4H, J = 6.8 Hz), 2.43 
(s, 2H), 1.56-1.60 (m, 4H), 1.24 (s, 12H), 0.82-0.85 (m, 6H); HRMS calculated for 
C41H48O10Na (M + Na
+
): 723.31397. Found: 723.31323. 
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Compound 64 
Compound 63 (1.05 g, 1.49 mmol) was dissolved in DCM and flushed with N2. PBr3 
(354 μL, 3.73 mmol) was added dropwise via syringe, and the mixture was stirred at 
room temperature for 6 hours. The mixture was cooled to 0 °C and quenched with 
saturated sodium bicarbonate solution, and then extracted with DCM, dried over Na2SO4 
and filtered. The DCM was removed under reduced pressure to yield compound 64 (1.16 
g, 94%) as a brown solid (mp 62 °C).  
1
H NMR (300 MHz, CDCl3) δ 8.49 (d, 2H, J = 
9.6), 7.85 (d, 2H, J = 9.3), 7.30 (d, 2H, J = 9.6), 7.19 (d, 2H, J = 9.3), 6.28 (s, 1H), 5.26 
(s, 1H), 5.06 (dd, 4H, J = 10.2, 27.2), 4.82 (s, 4H), 4.19 (t, 4H, J = 6.6), 2.42 (s, 2H), 
1.57-1.64 (m, 4H), 1.20-1.25 (m, 12H), 0.80-0.84 (m, 6H); 
13
C NMR (75 MHz, CDCl3) δ 
169.0, 151.8, 149.4, 128.5, 127.4, 125.1, 123.5, 121.0, 120.0, 118.9, 114.4, 91.3, 66.9, 
65.6, 31.3, 28.5, 26.8, 25.5, 24.7, 23.0, 22.5, 13.9; IR (neat, cm
−1
) 3428, 2958, 2921, 
2852, 1753, 1638, 1593, 1201, 1074; HRMS calculated for C41H46Br2O8Na (M + Na
+
): 
847.14517. Found: 847.14414. 
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Compound 65 
Compound 59 (101 mg, 0.287 mmol) as dissolved in 11 mL of DMF and flushed with N2. 
A 1.0 M solution of LiHMDS in THF (252 μL, 0.252 mmol) was added by syringe and 
the mixture was stirred for 15 minutes. Compound 64 (94.8 mg, 0.115 mmol) was 
dissolved in 4 mL of DMF and added by syringe, and the flask that contained compound 
64 was rinsed with 1 mL DMF which was also added to the reaction mixture by syringe. 
The reaction was stirred at room temperature for 17 hours. DMF was removed under 
reduced pressure and the mixture was purified by column chromatography on silica (0-
10% Et2O/DCM). The product was dried and rinsed with acetone to wash away 
remaining impurities to yield compound 65 (92.7 mg, 59% yield) as an off-white solid. 
1
H NMR (500 MHz, CDCl3) δ 9.99 (s, 2H), 8.55 (d, 2H, J = 9.5 Hz), 8.01 (d, 2H, J = 
8.0), 7.93 (d, 2H, J = 8.5 Hz), 7.80 (s, 2H), 7.65 (d, 2H, J = 8.0 Hz), 7.32 (d, 4H, J = 9.5 
Hz), 6.78-6.88 (m, 6H), 6.13 (s, 1H), 5.29 (s, 4H), 5.20 (s, 1H), 4.76 (s, 4H), 4.57 (s, 4H), 
4.10-4.15 (m, 4H), 4.00-4.03 (m, 4H), 2.30 (s, 2H), 1.54-1.55 (m, 4H), 1.41 (s, 4H), 1.21-
1.26 (m, 12H), 1.09-1.12 (m, 12H), 0.79-083 (m, 6H), 0.74-0.76 (m, 6H). 
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Compound 66 
Compound 65 (27.6 mg, .0201 mmol) was dissolved in 4 mL of THF, 3 mL of MeOH 
was added, then 2 mL of a 2M solution of aqueous NaOH. The mixture was stirred at 
room temperature for 13 hours. The solvent was removed by blowing N2 over it. The 
solid was suspended in 5 mL of 1M HCl, centrifuged and the liquid was decanted. The 
solid was again suspended in 1M HCl, centrifuged and the liquid decanted twice more, 
and then the same suspension/centrifugation process was followed two times each for 
methanol, THF, and methylene chloride to yield compound 66 (0.15 g, 75%) as a pale 
yellow solid. 
1
H NMR (500 MHz, d6-DMSO) δ 9.97 (s, 2H), 8.79 (d, 2H, J = 9.5 Hz), 
8.09-8.16 (m, 6H), 7.62 (d, 4H, J = 8.5 Hz), 7.52 (d, 2H, J = 9.5 Hz), 7.34 (d, 2H, J = 1.6 
Hz), 6.90 (d, 2H, J = 9.0 Hz), 6.85 (dd, 2H, J = 1.6, 8.5 Hz), 6.22 (s, 1H), 6.01-6.04 (m, 
4H), 5.55 (s, 1H), 5.01 (s, 4H), 2.26 (s, 2H). 
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Compound 67 
Compound 66 (7.9 mg, 0.0076 mmol) was dissolved in 0.5 mL of DMSO and 0.1 mL of 
hydrazine hydrate, 85% in water, and 1 drop of HCl were added. The reaction mixture 
was stirred for 13 hours and the DMSO was removed by blowing nitrogen over it. The 
solid was suspended in 1 mL of 1M HCl, centrifuged and the liquid was decanted. The 
solid was again suspended in 1M HCl, centrifuged and the liquid decanted twice more, 
and then the same suspension/centrifugation process was followed three times each for 
methanol, THF, and methylene chloride to yield compound 67 (6.1 mg) as a white solid 
that is insoluble in anything except basic water and acidic DMSO. 
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